March 21 (Fri) AM Special Lecture 1 特別講演 1 Room 2(Tokyo International Forum, C Block 4! 5F, Hall C) 8:30−9:15 Chairperson: Shinichi Takamoto(Mitsui Memorial Hospital, Tokyo) New Insights Regarding the Pathogenesis and Modification of Marfan Syndrome and Related Disorders Harry Dietz(Johns Hopkins University School of Medicine, USA) 129 March 21 AM March 21 (Fri) AM March 21 AM Special Lecture 2 特別講演 2 Room 2(Tokyo International Forum, C Block 4! 5F, Hall C) 9:15−10:00 Chairperson: Koichi Node(Department of Cardiovascular Medicine, Saga University, Saga) Adipokine Involvement in Cardiovascular Disease Kenneth Walsh(Boston University School of Medicine, USA) 130 March 21 (Fri) AM Special Lecture 3 特別講演 3 Room 2(Tokyo International Forum, C Block 4! 5F, Hall C) 11:10−11:55 Chairperson: Makiko Ueda(Department of Pathology, Osaka City University Graduate School of Medicine, Osaka) Update on the Pathophysiology of Acute Myocardial Infarction Peter Libby(Brigham and Women’s Hospital and Harvard Medical School, USA) 131 March 21 AM March 21 (Fri) AM March 21 AM Special Lecture 4 特別講演 4 Room 2(Tokyo International Forum, C Block 4! 5F, Hall C) 11:55−12:40 Chairperson: Issei Komuro(Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo) Genetic Causes of Human Heart Disease Christine E. Seidman(Brigham & Women’s Hospital and Harvard Medical School, USA) 132 3月21日(金)午前 シンポジウム 1 (CAD) 第 4 会場(東京国際フォーラム B ブロック 7F ホール B7(2)) 8:30−10:00 冠循環を見直す:心筋虚血の発生機序から評価まで 座長: 下川 宏明(東北大学 山岸 正和(金沢大学 循環器内科学) 臓器機能制御学・循環器内科) 1.Concepts and Limitations of Coronary Flow Reserve to Evaluate Myocardial Ischemia 盛 英三(東海大学 生理科学) 2.Trend Pathological Aspects of Myocardial Infarction in the Reperfusion Era 松本 学(国立循環器病研究センター 臨床検査部 病理) 3.Important Role of the Adventitia in the Pathogenesis of Coronary Hyperconstricting Responses after Drug! Eluting Stent Implantation in Pigs in Vivo 西宮 健介(東北大学 循環器内科) 4.Instantaneous Wave Free Ratio (iFR) as the New Adenosine Free Resting Parameter to Detect Ischemia Causing Stenosis 松尾 仁司(岐阜ハートセンター 循環器内科) 5.Long! term Outcome after Deferral of Revascularization in Patients with Intermediate Coronary Stenosis and Gray! Zone Fractional Flow Reserve 塩野 泰紹(和歌山県立医科大学 循環器内科学) 6.Impact of Fractional Flow Reserve after 2nd! generation Drug! eluting Stent Deployment on Clinical Outcome 寺井 英伸(金沢循環器病院 循環器科) 133 March 21 AM March 21 (Fri) AM March 21 AM Symposium 6 (HF) Room 3(Tokyo International Forum, B Block 7F, Hall B7 (1)) 8:30−10:00 Molecular Mechanism for Myocardial Hypertrophy and Heart Failure Chairpersons: Yoshihiko Saito(The First Department of Internal Medicine, Nara Medical University, Kashihara) Gerd Hasenfuss(University Medical Center Goettingen, Georg!August University Goettingen, Germany) Keynote Lecture: Excitation" Contraction Coupling in Human Heart Hypertrophy and Failure Gerd Hasenfuss(University Medical Center Goettingen, Georg!August University Goettingen, Germany) 1.Dissociation of Calmodulin from RyR2 Plays a Key Role in Diastolic Ca2+ Leak from Sarcoplasmic Reticulum in Pressure" overload Heart Failure Takeshi Yamamoto(Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube) 2.Dynamic Crosstalk at the Cell and Organ Levels in the Cardiac Adaptive Response and Heart Failure Ichiro Manabe(Department of Cardiovascular Medicine, The University of Tokyo Graduate School of Medicine, Tokyo) 3.Regulatory Mechanisms of Post" infarction Inflammation and Left Ventricular Remodeling Toshihisa Anzai(Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka) 4.Perturbation of the Titin! MURF1 Signaling Complex is Associated with Cardiac Hypertrophy in a Fish Model and in Human Patients Shinji Makino(Department of Cardiology, Keio University School of Medicine, Tokyo) 5.Molecular Mechanism of Gender Difference in Heart Failure Caused by Lamin A! C Mutations Akinori Kimura(Department of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University, Tokyo) 134 3月21日(金)午前 シンポジウム 7 (HT) 第 22 会場(東京商工会議所 7F 国際会議場) 8:30−10:00 高血圧の EBM 座長: 檜垣 實男(愛媛大学 光山 勝慶(熊本大学 循環器・呼吸器・腎高血圧内科学) 生体機能薬理学) 1.Should We Change the Target of Blood Pressure Control for Type 2 Diabetic Patients? 副島 弘文(熊本大学 循環器内科学) 2.Blood Pressure Lowering in High! risk Population―HIJ! CREATE Sub! study― 小川 洋司(東京女子医科大学 循環器内科学) 3.Optimal Target Range of Blood Pressure Control after Acute Myocardial Infarction Determined by the CART Analysis 松本 專(大阪大学 循環器内科学) 4.Clinical Significance of Low Diastolic Blood Pressure in Development of De! Novo Heart Failure―A Report From the CHART! 2 Study― 高田 剛史(東北大学 循環器内科) 5.Effects of the Calcium Channel Blocker! based Combinations on Blood Pressure Variability and Stroke Risk: Post! hoc Analysis of the COPE Trial 梅本 誠治(山口大学 臨床試験支援センター) 6.Blood Pressure Variability, Antihypertensive Agents and Their Effects on the Cardiovascular Disease 永井 道明(自治医科大学 循環器内科学) 135 March 21 AM 3月21日(金)午前 March 21 AM ラウンドテーブルディスカッション 1 (A) 第 21 会場(東京商工会議所 4F 東商ホール) 8:30−10:00 心房細動のアブレーション治療 座長: 高月 誠司(慶應義塾大学 循環器内科) 熊谷 浩一郎(福岡山王病院 ハートリズムセンター) 1.Ablation Strategy Based on Pulmonary Vein Isolation and Non! pulmonary Vein Trigger Ablation for Non! paroxysmal Atrial Fibrillation 桑原 大志(横須賀共済病院 循環器センター 内科) 2.Identification of Persistent Atrial Fibrillation Patients to Whom Pulmonary Vein Isolation Alone was Enough to Maintain Sinus Rhythm 井上 耕一(桜橋渡辺病院 心臓血管センター) 3.Coronary Sinus Ablation in Patients with Persistent Atrial Fibrillation 松尾 征一郎(東京慈恵会医科大学 循環器内科) 4.The Role of High! Freaquency Stimulation Guided Ganglionated Plexus Ablation for Persistent and Long! lasting Persistent Atrial Fibrillation 山城 荒平(豊橋ハートセンター 循環器内科) 5.Intracardiac Ultrasound for Left Atrial Navigation on Catheter Ablation for Atrial Fibrillation 藤生 克仁(東京大学 循環器内科) 136 3月21日(金)午前 ラウンドテーブルディスカッション 2 (A) 第 19 会場(JP タワー 4F カンファレンスルーム A) 11:10−12:40 CRT! D の長期予後 座長: 奥村 健二(土岐市立総合病院 内科) 因田 恭也(名古屋大学 循環器内科学) 1.Long! term Clinical Outcomes after CRT. Insights from CUBIC Registry 安藤 献児(小倉記念病院 循環器内科) 2.Prognosis of Very Severe Heart Failure Patients with CRT! D 朝田 一生(東京大学 循環器内科) 3.Long! term Variations of Response to Cardiac Resynchronization Therapy and Lethal Ventricular Arrhythmia 野田 崇(国立循環器病研究センター 心臓血管内科) 4.Relationship of Mechanical Dyssynchrony to Long! Term Clinical Outcome after Cardiac Resynchronization Therapy with Defibrillator 加藤 寛之(名古屋大学 循環器内科学) 5.Myocardial Contractile Reserve and Long! term Prognosis after Cardiac Resynchronization Therapy 新井 光太郎(東京女子医科大学 循環器内科学) 137 March 21 AM March 21 (Fri) AM March 21 AM Roundtable Discussion 3 (CAD) Room 21(The Tokyo Chamber of Commerce and Industry, 4F, Tosho Hall) 11:10−12:40 Issues in Stent Thrombosis Following Drug! eluting Stent Implantation Chairpersons: Yoshihisa Nakagawa(Department of Cardiology, Tenri Hospital, Tenri) Junya Ako(Cardiovascular Medicine, Kitasato University, Sagamihara) 1.Stent Thrombosis is a Problem in the Past Kengo Tanabe(Division of Cardiology, Mitsui Memorial Hospital, Tokyo) 2.DAPT Duration can be Shortened in the Second Generation DES Era by Stopping Aspirin Earlier Ken Kozuma(Department of Cardiology, Teikyo University Hospital, Tokyo) 3.Expectation for Novel Antiplatelet Agents Yoshihiro Morino(Division of Cardiology, Department of Internal Medicine, Iwate Medical University, Morioka) 138 3月21日(金)午前 トピック 1 (A) 第 19 会場(JP タワー 4F カンファレンスルーム A) 8:30−10:00 植込み型 VAD の適応と成績 座長: 山崎 健二(東京女子医科大学 心臓血管外科) 山本 一博(鳥取大学 病態情報内科学) 1.Management of Candidates for Cardiac Transplantation―From the Standpoints of Internal Medicine Physicians 猪又 孝元(北里大学 循環器内科学) 2.Clinical Results of Implantable Ventricular Assist Device from J! MACS 中谷 武嗣(国立循環器病研究センター 移植部) 3.Implantable LVAD can be Indicated in the Setting of Bridge to Decision? 絹川 弘一郎(東京大学 重症心不全治療開発講座) 4.Biventricular Support with Implantable Continuous! flow VADs: Osaka University Experience 戸田 宏一(大阪大学 心臓血管外科) 5.Current Status of Bridge to Transplant Treatment with Implantable Ventricular Assist Device 西中 知博(東京女子医科大学 心臓血管外科) 139 March 21 AM 3月21日(金)午前 March 21 AM トピック 2 (HT) 第 20 会場(JP タワー 5F カンファレンスルーム B) 8:30−10:00 睡眠・サーカディアンリズムと高血圧・循環器疾患 座長: 前村 浩二(長崎大学 循環病態制御内科学) 塩見 利明(愛知医科大学 睡眠科) 1.Pathophysiology of Circadian Rhythm Sleep Disorders 内山 真(日本大学 精神医学系) 2.Chronomics of Heart Rate and Blood Pressure Variabilites 大塚 邦明(東京女子医科大学 時間医学老年総合内科) 3.Circadian Rhythms and Cardiometabolic Disease Mukesh Jain(Case Western Reserve University, USA) 4.Systems and Synthetic Biology of Biological Timings 上田 泰己(東京大学 機能生物学専攻・システムズ薬理学教室) 140 3月21日(金)午前 トピック 3 (CAD) 第 5 会場(東京国際フォーラム D ブロック 7F ホール D7) 11:10−12:40 内科と外科のハイブリッド治療 座長: 大木 隆生(東京慈恵会医科大学 一色 高明(帝京大学 内科) 外科学講座) 1.Heart Team Approach to Achieve Better Outcome in Transcatheter Aortic Valve Implantation 林田 健太郎(慶應義塾大学 循環器内科) 2.The Importance of the Heart Team in TAVR; From the Surgical Point of View 高梨 秀一郎(榊原記念病院) 3.Carotid Artery Stenosis Complicated with Severe Heart Disease 伊苅 裕二(東海大学 循環器内科学) 4.Hybrid CABG; Off! pomp CABG Continuing Aspirin Early after DES Implantation 樋上 哲哉(札幌医科大学 心臓血管外科学) 5.Totally Endovascular Aneurysm Repair for Arch Aneurysms 金岡 祐司(東京慈恵会医科大学 外科学講座 血管外科) 6.Hybrid Revascularization for Peripheral Arterial Disease (PAD) 東 信良(旭川医科大学 循環・呼吸・腫瘍病態外科学) 7.Future Perspective on Hybrid Therapy Regarding Cardiovascular Diseases 原 英彦(東邦大学医療センター大橋病院 循環器内科) 141 March 21 AM 3月21日(金)午前 March 21 AM トピック 4 (O) 第 22 会場(東京商工会議所 7F 国際会議場) 11:10−12:40 心臓シミュレーター 座長: 杉浦 清了(東京大学 新領域創成科学研究科) 中沢 一雄(国立循環器病研究センター研究所 研究情報基盤管理室) 1.Clincal Application of Multi! scale Heart Simulator, UT! Heart 杉浦 清了(東京大学 新領域創成科学研究科) 2.Technological Development of Heart Simulators for Various Computer Platforms in the Medical and Health! care Fields 中沢 一雄(国立循環器病研究センター研究所 研究情報基盤管理室) 3.In Silico Arrhythmology: To Unlock the Future of Arrhythmia Treatment 芦原 貴司(滋賀医科大学 循環器内科・不整脈センター) 142 3月21日(金)午前 コントロバーシー 1 (CAD) 第 3 会場(東京国際フォーラム B ブロック 7F ホール B7(1)) 11:10−12:40 大動脈瘤治療:ステントグラフト vs. Open Surgery 座長: 大北 裕(神戸大学 外科学講座心臓血管外科分野) 宮田 哲郎(東京大学 血管外科) 1.Endovascular Treatment for Thoracoabdominal Aneurysm or Dissection 加藤 雅明(森之宮病院 心臓血管外科) 2.EVAR or Open, a Wise Man Changes His Mind 三井 信介(製鉄記念八幡病院 血管病センター) 3.Strategy for AAA Repair: Open Surgical Repair or EVAR? 重松 邦広(東京大学 血管外科) 4.TEVAR vs Open―Appropriate Applications of TEVAR Alone and Open Surgery Alone are the Best Situation under the Present Conditions― 明石 英俊(久留米大学 外科学) 5.Lessons Learned from Mid! term Result of Hybrid Arch TEVAR and Its Solutions 松田 均(国立循環器病研究センター 心臓血管外科) 6.Open Versus Endovascular Thoracic Aortic Repair 椎谷 紀彦(浜松医科大学 第一外科) 143 March 21 AM 3月21日(金)午前 March 21 AM ミート・ザ・エキスパート 1 (IM) 第 5 会場(東京国際フォーラム D ブロック 7F ホール D7) 8:30−10:00 心臓 MRI! CT の使い方 座長: 栗林 幸夫(慶應義塾大学 放射線診断科) 佐久間 肇(三重大学 臨床医学系講座 放射線医学) 1.Possibility of MRI for Detecting Vulnerable Coronary Plaques 野口 暉夫(国立循環器病研究センター 心臓血管内科) 2.Comparison of CMR and Histopathology Findings in Cardiomyopathy and Myocarditis 木村 文子(埼玉医科大学国際医療センター 画像診断科) 3.Acute Coronary Syndrome and Plaque Assessment by Coronary Computed Tomography Angiography 元山 貞子(藤田保健衛生大学 循環器内科学) 4.Quantitative Analysis of Myocardial Perfusion Using Dual" source Computed Tomography 北川 覚也(三重大学 中央放射線部) 5.Radiation" Dose" Lowering Effect of Landiolol Hydrochloride in Coronary Angiography Using Computed Tomography: DELIGHT Study 山田 祥岳(慶應義塾大学 放射線診断科) 144 3月21日(金)午前 ミート・ザ・エキスパート 2 (HF) 第 20 会場(JP タワー 5F カンファレンスルーム B) 11:10−12:40 心臓リハビリテーションの実際 座長: 後藤 葉一(国立循環器病研究センター 心臓血管内科) 長山 雅俊(榊原記念病院 循環器内科) 1.Prehabilitation and Early Phase of Postoperative Rehabilitation after Cardiac Surgery 齊藤 正和(榊原記念病院 理学療法科) 2.The Practice of Cardio! pulmonary Exercise Test (CPX) in Cardiac Rehabilitation 白石 裕一(京都府立医科大学 循環器内科) 3.Cardiac Rehabilitation in Patients with Noncardiac Morbidities 牧田 茂(埼玉医科大学国際医療センター 心臓リハビリテーション科) 4.How to Operate Outpatient Cardiac Rehabilitation as a Disease Management Program 後藤 葉一(国立循環器病研究センター 心臓血管内科) 145 March 21 AM 3月21日(金)午前 March 21 AM Late Breaking Clinical Trials 1 第 6 会場(東京国際フォーラム D ブロック 5F ホール D5) 8:30−10:10 座長: 島本 和明(札幌医科大学) 島田 和幸(新小山市民病院) 1.Treatment of Venous Thromboembolism in East! Asian (Including Japanese) Patients―A Hokusai! VTE Subanalysis Mashio Nakamura(Mie University, Tsu) 2.Edoxaban versus Warfarin in East! Asian (Including Japanese) Patients with Atrial Fibrillation―An ENGAGE AF! TIMI 48 Sub! analysis Yukihiro Koretsune(Osaka National Hospital, Osaka) 3.Effects of AMG 145 in Hypercholesterolemic, Statin! treated, Japanese Patients at High Cardiovascular Risk: Results from the Phase II YUKAWA Study 平山 篤志(日本大学 循環器内科) 4.Randomised Double! blind Comparison of Placebo and Active Drugs for Effects on Risks Associated with Blood Pressure Variability in Syst! Eur Trial Azusa Hara(Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Belgium) 146 March 21 (Fri) AM Featured Research Session 1 (CAD) Room 9(Tokyo International Forum, Glass Building 4F, G409) 8:30−10:10 Topics of Stem Cells and Atherosclerosis Chairpersons: Elena Aikawa(Brigham and Women’s Hospital, Harvard Medical School, USA) Youichi Katoh(Department of Cardiovascular Medicine, Juntendo University, Urayasu Heart Center, Chiba) Keynote Lecture: Novel Mechanisms of Vascular Calcification Elena Aikawa(Brigham and Women’s Hospital, Harvard Medical School, USA) FRS-001 Evidence for a Protective Role of Fibroblast Growth Factor 23 against Vascular Calcification Takehiro Nakahara(Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, Maebashi) FRS-002 Characteristics of Novel Capillary Derived Stem Cells (CapSCs) from Vasa Vasorum of Injured Vascular Walls Maki Kabara(Division of Cardiology and Nephrology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa) FRS-003 Inhibition of microRNA" 195 Ameliorates Aged Stem Cell Function for Cardiac Repair through Telomere Re" lengthening Motoi Okada(Department of Cardiology, Asahikawa Medical University, Asahikawa) FRS-004 The Establishment of Vascular Cell Differentiation System from Human ES! iPS Cells and Its Application for the Clarification of Vascular Pathology Daisuke Taura(Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto) FRS-005 Nanoparticle" Mediated Targeting of Pitavastatin into Reperfused Myocardium Reduces Ischemia" Reperfusion Injury in a Preclinical Pig Model Kenzo Ichimura(Department of Cardiovascular Medicine, Kyushu University, Fukuoka) 147 March 21 AM March 21 (Fri) AM March 21 AM Featured Research Session 2 (IM) Room 18(JP Tower, 4F, Hall 3) 8:30−10:10 Coronary Imaging Chairpersons: Jagat Narula(Mount Sinai Hospital, USA) Takashi Akasaka(Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama) Keynote Lecture: TBA Jagat Narula(Mount Sinai Hospital, USA) FRS-006 First! pass Myocardial Perfusion Imaging Plus 64! row Detector Computed Tomography Angiography is Feasible for Assessing Coronary Artery Disease Kazuhiro Osawa(Department of Cardiovascular Medicine, Okayama University, Okayama) FRS-007 Frequency and Natural Course of Silent Plaque Rupture: A Serial OCT Study Teruyoshi Kume(Department of Cardiology, Kawasaki Medical School, Kurashiki) FRS-008 Localization of Coronary Hyperintense Plaques Identified by Noncontrast T1! weighted MRI: Correlate to Plaque Morphology and Clinical Severity of Angina Pectoris Kenji Matsumoto(Department of Internal Medicine and Cardiology, Osaka City University School of Medicine, Osaka) FRS-009 Additive Value of MR Blood Flow Measurement in the Coronary Sinus to Detect Functionally Significant Coronary Stenosis in Multivessel Disease Shiro Nakamori(Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu) FRS-010 Long Term Follow Up of the Patients with or without High Risk Plaque Detected by Coronary Computed Tomography Angiography Hajime Ito(Department of Cardiology, Fujita Health University, Toyoake) 148 March 21 (Fri) AM Featured Research Session 3 (A) Room 6(Tokyo International Forum, D Block 5F, Hall D5) 11:00−12:40 Sudden Cardiac Death! Ventricular Fibrillation Chairpersons: Kaoru Sugi(Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo) Masaomi Chinushi(Department of Health Sciences, Niigata University, Niigata) Keynote Lecture: Sudden Cardiac Death in Japanese People Kaoru Sugi(Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo) FRS-011 Papillary Muscle Hypertrophy is Possibly Associated with the Genesis of J" waves Yuki Ebata(Department of Cardiology and Clinical Examination, Oita University, Oita) FRS-012 Extremely Delayed Conduction Detectable on Magnetocardiography Predicts Lethal Arrhythmic Events in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Yoshitaka Kimura(Department of Cardiology, National Cerebral and Cardiovascular Center, Suita) FRS-013 Inferior J" wave is Associated with Ventricular Fibrillation Related Poor Prognosis in Patients with Anterior ST" elevation Myocardial Infarction: Long" term Outcome Keisuke Okawa(Department of Cardiovascular Medicine, Kagawa Prefectural Central Hospital, Takamatsu) FRS-014 The Utility of T" wave Alternance and Signal" averaged Electrocardiogram Parameters after Administration of Pilsicainide for Risk Assessment in Brugada Syndrome Keiko Maeda(Department of Cardiology, Osaka City University Graduate School of Medicine, Osaka) FRS-015 The Relationship between the Types of Mutations in Lamin A! C Gene and Cardiac Phenotypes: Genetic Risk Factor for Dilated Cardiomyopathy Suguru Nishiuchi(Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto) 149 March 21 AM March 21 (Fri) AM March 21 AM Featured Research Session 4 (CAD) Room 9(Tokyo International Forum, Glass Building 4F, G409) 11:00−12:40 ACS! AMI (Clinical! Diagnosis! Pathophysiology! Treatment) Chairpersons: Tetsuji Miura(Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University, Sapporo) Teruo Inoue(Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu) Keynote Lecture: Plaque Quality Evaluation after Statin Treatment in Acute Coronary Syndrome Teruo Inoue(Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu) FRS-016 Factors Influencing Elapsed Time from Onset to Emergency Medical Service Call in Patients with Acute Myocardial Infarction Masao Yamasaki(Department of Cardiology, NTT Medical Center Tokyo, Tokyo) FRS-017 Remote Ischemic Preconditioning Procedure of the Upper Arm Reduces Contrast" induced Acute Kidney Injury in Patients with ST" Elevation Myocardial Infarction Toshiaki Yamanaka(Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama) FRS-018 Prognostic Impact of the Staged PCI Strategy for Non" culprit Lesions in STEMI Patients with Multivessel Disease Undergoing Primary PCI Toshiaki Toyota(Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto) FRS-019 Clinical Appearance of Glycemic Variability in Patients with ST" Elevated Myocardial Infarction Evaluated with Continuous Glucose Monitoring System (CGMS) Masahide Tokue(Division of Cardiology, Toho University Ohashi Medical Center, Tokyo) FRS-020 Endothelial Dysfunction in Patients with Acute Phase of ST" segment Elevation Myocardial Infarction; Effects of Statins Ken Arai(Department of Cardiology, Tokyo Metropolitan Hiroo Hospital, Tokyo) 150 3月21日(金)午前 教育セッション ビデオセッション I! 1 第 1 会場(東京国際フォーラム A ブロック 4F ホール A) 8:30−9:30 心房細動アブレーションの進歩 座長: 沖重 薫(横浜市立みなと赤十字病院 心臓病センター) 奥村 謙(弘前大学 循環呼吸腎臓内科学講座) 1.Cryoballoon Ablation for Atrial Fibrillation Marc Dubuc(Montreal Heart Institutes, Canada) 2.3D イメージング・コンタクトフォースガイド 心房細動アブレーション 木村 正臣(弘前大学 循環呼吸腎臓内科学) 151 March 21 AM 3月21日(金)午前 March 21 AM 教育セッション ビデオセッション I! 2 第 1 会場(東京国際フォーラム A ブロック 4F ホール A) 9:30−10:30 大動脈ステントグラフト 座長: 吉川 公彦(奈良県立医科大学 放射線科) 荻野 均(東京医科大学 心臓血管外科) 1.Hybrid Arch TEVAR における脳梗塞予防 松田 均(国立循環器病研究センター 心臓血管外科) 2.大動脈分枝部に対する分枝付きステントグラフトを用いた TEVAR 加藤 雅明(森之宮病院 心臓血管外科) 3.腹部大動脈破裂症例に対する緊急ステントグラフト内挿術 阪口 昇二(松原徳州会病院 大動脈ステントグラフト・血管内治療科) 152 3月21日(金)午前 教育セッション ビデオセッション I! 3 第 1 会場(東京国際フォーラム A ブロック 4F ホール A) 11:40−12:40 ASD 座長: 赤木 禎治(岡山大学病院 河村 朗夫(慶應義塾大学 循環器疾患集中治療部) 循環器内科) 1.ASD カテーテル閉鎖術の基本手技 矢崎 諭(国立循環器病研究センター 小児循環器科) 2.心腔内エコーガイドによる心房中隔欠損のカテーテル閉鎖術 河村 朗夫(慶應義塾大学 循環器内科) 3.高齢者の心房中隔欠損症に対するカテーテル閉鎖術 中川 晃志(岡山大学 循環器内科) 153 March 21 AM 3月21日(金)午前 March 21 AM 日本循環器学会 委員会セッション(学術委員会) 第 4 会場(東京国際フォーラム B ブロック 7F ホール B7(2)) 11:10−12:40 ガイドラインに学ぶ 1 2012(2011)!2013 年度活動新規ガイドライン作成班報告 座長: 筒井 裕之(北海道大学 循環病態内科学) 1.先天性心疾患、心臓大血管の構造的疾患(Structural heart disease)に 対するカテーテル治療のガイドライン 中西 敏雄(東京女子医科大学 循環器小児科) 2.災害時循環器疾患の予防・管理に関するガイドライン 下川 宏明(東北大学 循環器内科学) 3.慢性肺動脈血栓塞栓症に対する balloon pulmonary angioplasty の適 応と実施法に関するワーキンググループ 伊藤 浩(岡山大学 機能制御学(循環器内科)) 154 March 21 (Fri) AM Young Investigator’s Award Finalists Lectures (Clinical Research) Young Investigator’s Award Clinical Research 部門審査講演 Room 10(Tokyo International Forum, Glass Building 5F, G502) 8:30−10:30 Chairperson: Hisao Ogawa(Department of Cardiovascular Medicine, Kumamoto University, Kumamoto) 1.Morphometric and Quantitative Analysis in Cardiomyocyte’s Nucleus were Associated with Poor Outcome in Patients with Idiopathic Dilated Cardiomyopathy Machiko Kanzaki(Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita) 2.Impact of Interventional Therapies for Chronic Thromboembolic Pulmonary Hypertension: Comparison of Clinical Outcomes of Pulmonary Endarterectomy vs. Percutaneous Transluminal Pulmonary Angioplasty Masaharu Kataoka(Division of Cardiology, Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo) 3.Association Between Non! High! Density Lipoprotein Cholesterol and Pathological Changes in Coronary Arteries Among Population! Based Autopsy Samples in Japan: The Hisayama Study Kensuke Izumaru(Department of Medicine and Clinical Science, Kyushu University Graduate School of Medical Sciences, Fukuoka) 4.Utility of Non! Invasive Endothelial Function Test for Prediction of Deep Vein Thrombosis After Total Hip or Knee Arthroplasty Hiroyuki Suzuki(Division of Cardiology, Yokohama City University Medical Center, Yokohama) 155 March 21 AM March 21 (Fri) AM March 21 AM Young Investigator’s Award for International Students Finalists Lectures 国際留学生 YIA 審査講演 Room 10(Tokyo International Forum, Glass Building 5F, G502) 10:40−12:40 Chairperson: Toyoaki Murohara(Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya) 1.Therapeutic Vaccine Against DPP4 Improves Glucose Metabolism in Mice Zhengda Pang(Department of Geriatric Medicine and Nephrology, Osaka University Graduate School of Medicine, Osaka) 2.Renin Inhibition Reduces Atherosclerotic Plaque Neovascularization and Stabilizes Established Atherosclerotic Plaques Hongxian Wu(Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya) 3.Uric Acid Enhanced Kv1.5 Channel Expression in Atrial Myocytes via Activation of Uric Acid Transporters, Xanthine Oxidase! Dependent Oxidative Stress, ERK Pathway Nani Maharani(Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Tottori University Graduate School of Medical Science, Yonago) 4.Depletion of Cardiac 14! 3! 3eta Protein Adversely Influences Pathologic Cardiac Remodeling via Exacerbation of Inflammation, Endoplasmic Reticulum Stress, and Suppression of Regeneration After Coronary Artery Ligation in Mice Somasundaram Arumugam(Department of Clinical Pharmacology, Niigata University of Pharmacy and Applied Life Sciences, Niigata) 5.Molecular and Cellular Mechanisms of Right Ventricular Remodeling in Pulmonary Hypertension Suvd Nergui(Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai) 156 March 21 (Fri) AM Oral Presentation (English) 1 (A) Room 7(Tokyo International Forum, D Block 1F, Hall D1) 8:30−10:00 Arrhythmia (Basic, Diagnosis) Chairpersons: Hiroshi Inoue(Second Department of Internal Medicine, University of Toyama, Toyama) Kaoru Tanno(Department of Cardiovascular Medicine, Cardiovascular Center, Koto!toyosu Hospital, Showa University School of Medicine, Tokyo) OE-001 Role of Spleen! Derived Interleukin! 10 in High! Fat! Diet! Induced Inflammatory Atrial Fibrosis and Fibrillation Hidekazu Kondo(Department of Cardiology and Clinical Examination, Oita University Faculty of Medicine, Yufu) OE-002 Withdrawn OE-003 Vidarabine, an Anti! herpesvirus Agent, Attenuates Ca2+ Leak from Sarcoplasmic Reticulum and Prevents Atrial Fibrillation in Mice Kenji Suita(Cardiovasucular Research Institute, Yokohama City Universty Graduate School of Medicine, Yokohama) OE-004 Paradoxical Behavior of QT! rate Dependence in Patients with Lethal Ventricular Arrhythmias: Results of 5 Years Follow Up Ahmed Talib(Asahikawa Medical University, Asahikawa) OE-005 The Relationship of the Prevalence of J Wave and TWA in the Patients with Vasospastic Angina Yukihiro Inamura(Department of Cardiology, Yokohama Minami Kyosai Hospital, Yokohama) OE-006 The Difference in the Waveforms during Pacemapping at Subdivided Portions within the Outflow Tract: The Usefulness of Synthesized 18! lead Electrocardiograms Miyako Igarashi(Cardiovascular Division, Faculty of Medicine, University of Tsukuba, Tsukuba) 157 March 21 AM March 21 (Fri) AM March 21 AM Oral Presentation (English) 2 (A) Room 8(Tokyo International Forum, Glass Building 4F, G402) 8:30−10:00 Cardiac Sudden Death! ICD! CRT Chairpersons: Takashi Kurita(Division of Cardiovascular Center, Kinki University, Osaka) Kenji Ando(Department of Cardiology, Kokura Memorial Hospital, Kitakyushu) OE-007 Long" term Changes of Left Ventricular Systolic Function and Volume after Cardiac Resynchronization Therapy Ikutaro Nakajima(Division of Cardiology, National Cerebral and Cradiovascular Center Japan, Osaka) OE-008 Analysis of Prognosis of Patients with Cardiac Resynchronization Therapy" Defibrillator by the Different QRS Duration Akihiko Shimizu(Implantable Devices Registry and Assessment Committee of the Japanese Heart Rhythm Society, Tokyo) OE-009 Prospective Multicenter Trial of Fast Ventricular Tachycardia Termination by Anti" tachycardia Pacing in a Japanese Implantable Cardioverter" defibrillator Patients: The Satisfaction Study Tetsuya Watanabe(Cardiovascular Center, Kansai Rosai Hospital, Hyogo) OE-010 Spike to QRS Interval is a Novel Predictive Marker for Recurrence of Ventricular Tachycardia in Patients with ICD or CRT" D Naoya Kataoka(Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, Toyama) OE-011 Comparison between CRT" D and CRT" P in Elderly Patients: A Single Center Experience Yoshifumi Ikeda(Department of Cardiology, Saitama Medical University International Medical Center, Saitama) OE-012 Optimal Cut" off Value of Reverse Remodeling for Predicting Long" Term Outcome after Cardiac Resynchronization Therapy in Ischemic Cardiomyopathy Akinori Sugano(Department of Cardiology, Tsukuba Medical Center Hospital, Tsukuba) 158 March 21 (Fri) AM Oral Presentation (English) 3 (CAD) Room 11(Tokyo International Forum, Glass Building 5F, G510) 8:30−10:00 ACS! AMI (Clinical! Treatment) 1 Chairpersons: Hideo Fujita(Department of Cardiovascular Medicine, The University of Tokyo, Tokyo) Shinji Tayama(Division of Preventive Cardiology, Kumamoto University Hospital, Kumamoto) OE-013 The Analysis of Delay from First Medical Contact to Primary PCI for Patients with ST Elevation Myocardial Infarction in Tokyo Hideki Miyachi(Intensive and Cardiovascular Care Unit, Nippon Medical School Hospital, Tokyo) OE-014 Revascularization Strategy for the Hemodynamically Unstable non" ST Elevation Myocardial Infarction with Left Main Trunk Disease―Tokyo CCU Network Cohort Analysis― Hajime Fujimoto(Tokyo CCU Network Scientific Committee, Tokyo Metropolitan Geriatric Hospital, Tokyo) OE-015 Infarct Size as Estimated by QRS Score Combined with E! e’ Provide Useful Information in Patients with a First" time STEMI Noriaki Iwahashi(Division of Cardiology, Yokohama City University Medical Center, Yokohama) OE-016 On versus Off" hours Primary Percutaneous Coronary Intervention for ST" Elevation Myocardial Infarction: A Study of Yokohama Cardiovascular Workshop Yuya Kimura(Department of Cardiology, Department of Internal Medicine Yokohama Sakae Kyosai Hospital, Yokohama) OE-017 Clinical Value of Beta" blockers and Reperfusion Time in ST" Segment Elevated Myocardial Infarction; From ICAS Registry Shunsuke Maruta(Department of Cardiology, Tsukuba University School, Ibaraki) OE-018 Effects of Liraglutide, a Glucagon" Like Peptide" 1 Receptor Agonist, on Left Ventricular Remodeling and Function in Patients with Acute Myocardial Infarction Tsuyoshi Nozue(Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Yokohama) 159 March 21 AM March 21 (Fri) AM March 21 AM Oral Presentation (English) 4 (CAD) Room 12(Tokyo International Forum, Glass Building 6F, G602) 8:30−10:00 Coronary Revascularization! PCI (DES) 1 Chairpersons: Naoto Inoue(Department of Cardiology, Tokyo Kamata Hospital, Tokyo!Sendai Kousei Hospital, Sendai) Junya Shite(Department of Cardiology, Osaka Saiseikai Nakatsu Hospital, Osaka) OE-019 Evaluation of Inflammatory Reaction after the Second Generation Everolimus and Zotarolimus Eluting Stents Implantation in a Healthy Rabbit Model Sho Torii(Department of Cardiology, Tokai University School of Medicine, Isehara) OE-020 Midterm Outcomes of Stent Recoil with Stent Fracture after Various Drug" eluting Stent Implantation Masanobu Ohya(Department of Cardiology, Kurashiki Central Hospital, Kurashiki) OE-021 Angioscopic Evaluation of Neointimal Coverage from Four to Eight Months Following Everolimus" eluting Stent Implantation Masaki Awata(Kansai Rosai Hospital Cardiovascular Center, Amagasaki) OE-022 The Efficacy of Stentboost Technique during the Post" dilatation after Stent Implantation in Reducing the Stent" edge Restenosis Yoshiyuki Orihara(Department of Cardiology, Sakurabashi"Watanabe Hospital, Osaka) OE-023 The Incidence of Peri" stent Contrast Staining after Paclitaxel" coated Balloon Dilatation for In" stent Restenosis Lesions: A Comparison with Drug" eluting Stent Takeshi Tada(Department of Cardiology, Kurashiki Central Hospital, Kurashiki) OE-024 Clinical Efficacy of Newer Small Size DES (2.25mm) in Treating Small but Important Coronary Artery Lesions Ryuta Nakamura(Division of Cardiology, Heart Institute, Chiba Nishi General Hospital, Chiba) 160 March 21 (Fri) AM Oral Presentation (English) 5 (CAD) Room 13(Tokyo International Forum, Glass Building 6F, G610) 8:30−10:00 Vascular Disease (Therapy) 1 Chairpersons: Sugao Ishiwata(Department of Cardiology, Cardiovascular Center, Toranomon Hospital, Tokyo) Satoshi Takeshita(Department of Cardiology, Nagasaki Municipal Hospital, Nagasaki) OE-025 Impact of Post! procedural Minimum Stent Area on Long! term Outcomes after Stent Implantation in the Iliac Artery: An Intravascular Ultrasound Study Kojiro Miki(Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya) OE-026 The Impact of Endovascular Therapy for Aorto! iliac TASC D Lesions Yukiko Mizutani(Department of Cardiology, Sendai Kousei Hospital, Sendai) OE-027 Clinical Impact of Platelet Reactivity after Superficial Femoral Artery Stenting with Zilver PTXⓇ Kei Ichihashi(Department of Cardiology, Kokura Memorial Hospital, Kitakyushu) OE-028 Predictors of Limb Salvage and Survival of Octogenarian with Critical Limb Ischemia after Endovascular Therapy Kei Ichihashi(Department of Cardiology, Kokura Memorial Hospital, Kitakyushu) OE-029 Outcomes Following Endovascular Therapy with a Drug! eluting Stent (Zilver PTX) in the Femoropopliteal Artery Kiyonori Nanto(Kansai Rosai Hospital, Hyogo) OE-030 Vasculogenic Conditioning of Peripheral Blood Mononuclear Cells Coordinates Regenerative Potential via Expanding Endothelial Progenitor Cells, Anti! inflammatory Macrophages and T Lymphocytes Haruchika Masuda(Department of Regenerative Medicine Science, Tokai University School of Medicine, Isehara) 161 March 21 AM March 21 (Fri) AM March 21 AM Oral Presentation (English) 6 (HF) Room 14(Tokyo International Forum, Glass Building 7F, G701) 8:30−10:00 Cardiomyopathy! Hypertrophy (Basic! Clinical) 1 Chairpersons: Tetsuo Shioi(Department of Cardiovascular Medicine, Kyoto University, Kyoto) Hiroaki Kitaoka(Department of Cardiology, Neurology and Aging Science, Kochi University, Kochi) OE-031 MicroRNA" 451 Exacerbates Lipotoxicity in Neonatal Rat Cardiomyocytes, and High Fat Diet Induced Cardiac Hypertrophy in Mice through LKB1! AMPK Pathway Yasuhide Kuwabara(Department of Cardiovascular Medicine, Kyoto University School of Medicine, Kyoto) OE-032 HECT" Type Ubiquitin E3 Ligase ITCH Interacts with Thioredoxin" Interacting Protein and Ameliorates Reactive Oxygen Species" Induced Cardiotoxicity in Vioro and in Vivo Yoichiro Otaki(Yamagata University School of Medicine, Yamagata) OE-033 Extent of Late Gadolinium Enhancement in Cardiac Magnetic Resonance Predicts Major Adverse Cardiac Events in Hypertrophic Cardiomyopathy with Systolic Dysfunction Akira Funada(Department of Cardiology, National Cerebral and Cardiovascular Center, Suita) OE-034 Feasibitily of Alcohol Septal Ablation Using Nitroglycerin Tests for Refractory Hypertrophic Obstructive Cardiomyopaty with Labile Obstruction Mitsunobu Kitamura(Department of Cardiology, Nippon Medical School, Tokyo) OE-035 Acute Angled T Wave Inversion is a Specific ECG Sign of Hypertrophic Cardiomyopathy Naohito Yamasaki(Department of Cardiology, Kochi Medical School, Kochi) OE-036 Tissue Fibrosis of Myocardial Biopsy as a Novel Predictor for Adverse Cardiac Events in Patients with Hypertrophic Cardiomyopathy Yuko Wada(Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita) 162 March 21 (Fri) AM Oral Presentation (English) 7 (HF) Room 16(Tokyo International Forum, B2F, Seminar Room 2) 8:30−10:00 Valvular Heart Disease! Pericarditis! Cardiac Tumor 1 Chairpersons: Goro Matsumiya(Department of Cardiovascular Surgery, Chiba University, Chiba) Tetsuya Tohbaru(Department of Cardiovascular, Sakakibara Heart Institute, Tokyo) OE-037 The Impact of Pre" existing Artrial Fibrillation on Outcome after TAVI: Results from the FRANCE 2 Resitry Akira Furuta(Cardiologie Interventionnelle, Service Cardiologie, CHU, Hopital Henri! Mondor, France) OE-038 The Impact of Previous Acute Pulmonary Oedema on Prognosis after TAVI: Insight from FRANCE2 Registry Akira Furuta(Cardiologie Interventionnelle, Service Cardiologie, CHU, Hopital Henri! Mondor, France) OE-039 New Indicative Factor of Frailty Criteria in Elderly Patients Undergoing TAVI Akira Furuta(Cardiologie Interventionnelle, Service Cardiologie, CHU, Hopital Henri! Mondor, France) OE-040 Transcatheter Aortic Valve Implantation in High" Risk Patients with Severe Bicuspid Aortic Valve Stenosis Charis Costopoulos(Interventional Cardiology Unit, EMO!GVM Centro Cuore Columbus, Italy) OE-041 Mechanism of Post" Procedural Aortic Regurgitation after Transcatheter Aortic Valve Replacement: A Real" Time Three" Dimensional Transesophageal Echocardiography Study Kentaro Shibayama(Cedars!Sinai Heart Institute, USA) OE-042 Reduction of Regional Myocardial Wall Stress Improves Global Cardiac Performance in Patients with Transcatheter Aortic Valve Replacement for Aortic Stenosis Keitaro Domae(Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka) 163 March 21 AM March 21 (Fri) AM March 21 AM Oral Presentation (English) 8 (A) Room 7(Tokyo International Forum, D Block 1F, Hall D1) 11:10−12:40 Atrial Fibrillation (Basic, Pathophysiology) Chairpersons: Hideo Mitamura(Department of Cardiology, Tachikawa Hospital, Tokyo) Yuji Murakawa(Department of Internal Medicine, Mizonokuchi Hospital, Teikyo University School of Medicine, Kawasaki) OE-043 Catheter Ablation Affects the Flow! Mediated Dilatation Only for Patients with Paroxysmal Atrial Fibrillation Hirohiko Suzuki(Nagoya Daini Red Cross Hospital, Nagoya) OE-044 Spontaneous Termination of Human Atrial Fibrillation: Spectral Analysis of Surface Electrocardiograms during Holter ECG Recordings Akira Fujiki(Division of Cardiology, Shizuoka Red Cross Hospital, Shizuoka) OE-045 Plasma Levels of Oxidative Stress! Responsive Apoptosis! Inducing Protein (ORAIP) in Patients wih Atrial Fibrillation Yoshinori Seko(Division of Cardiovascular Medicine, Institute for Adult Diseases, Asahi Life Foundation, Tokyo) OE-046 The Electrophysiological Properties in Patients with Tachycardia! induced Cardiomyopathy Resulting from Rapid Atrial Fibrillation Akinori Sairaku(Department of Cardiology, Hiroshima University School of Medicine, Hiroshima) OE-047 Ramelteon Improves the Outcome of Catheter Ablation for Paroxysmal Atrial Fibrillation in the Patients with Dilated Left Atrium Monami Ando(Cardiovascular Center, Nagoya Daini Red Cross Hospital, Nagoya) OE-048 Ramelteon Suppress the Recurrence after Ablation in the Patients with Non! paroxysmal AF Monami Ando(Cardiovascular Center, Nagoya Daini Red Cross Hospital, Nagoya) 164 March 21 (Fri) AM Oral Presentation (English) 9 (CAD) Room 11(Tokyo International Forum, Glass Building 5F, G510) 11:10−12:40 ACS! AMI (Clinical! Treatment) 2 Chairpersons: Hiroshi Ikenouchi(Department of Cardiology, Japanese Red Cross Medical Center, Tokyo) Yuji Hamazaki(Division of Cardiology, Showa University, Tokyo) OE-049 Human Atrial Natriuretic Peptide for Acute Myocardial Infarction Reperfused with Coronary Intervention: An Assessment by Cardiac Magnetic Resonance Imaging Takayuki Onishi(Department of Cardiology, Hiratsuka Kyosai Hospital, Hiratsuka) OE-050 Preinfarction Angina Predicts Better Long" term Outcomes in Patients with ST" segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Tomohiko Taniguchi(Department of Cardiovascular Medicine, Kyoto University, Kyoto) OE-051 Using Landiolol before Primary Percutaneous Coronary Intervention Attenuates Myocardial Reperfusion Injury in Patients with ST" Segment Elevation Acute Myocardial Infarction Masayoshi Kiyokuni(Saiseikai Yokohamashi Nanbu Hospital, Yokohama) OE-052 The Relationship between the Volume of Epicardial Adipose Tissue and Infarct Size in Patients with a First STEMI: Cardiac MRI Study Masaomi Gohbara(Yokohama City University Medical Center, Yokohama) OE-053 Prognostic Significance of B" type Natriuretic Peptide in Patients with Acute Myocardial Infarction without Pump Failure―ALPS" AMI Subanalysis― Takashi Yanagisawa(Department of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto) OE-054 Impact of Beta" Blocker Therapy after Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction without Heart Failure: Sub" analysis of ALPS" AMI Study Hirofumi Hioki(Department of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto) 165 March 21 AM March 21 (Fri) AM March 21 AM Oral Presentation (English) 10 (CAD) Room 13(Tokyo International Forum, Glass Building 6F, G610) 11:10−12:40 Vascular Disease (Therapy) 2 Chairpersons: Yoshiaki Yokoi(Department of Cardiology, Kishiwada Tokushukai Hospital, Kishiwada) Yusuke Miyashita(Department of Advanced PAD Therapeutics, Shinshu University Hospital, Matsumoto) OE-055 Tocilizumab Ameliorates Vascular Inflammation and Clinical Symptoms in the Patients with Takayasu Arteritis Refractory to Glucocorticoids Yoshikazu Nakaoka(Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita) OE-056 Clinical Characteristics of Patients with Rutherford Classification IV Compared with V and VI Taketsugu Tsuchiya(Division of Trans!catheter Cardiovascular Therapeutics, Kanazawa Medical University Hospital, Kahoku) OE-057 The Effect of Statin Treatment on Patients with Femoropopliteal Artery Disease after Endovascular Therapy Yoshiaki Shintani(Department of Cardiology, Cardiovascular Center, Shin!Koga Hospital, Kurume) OE-058 Clinical Outcomes of Critical Limb Ischemia with Tissue Loss after Complete Wound Healing Norihiro Kobayashi(Department of Cardiology, Saiseikai Yokohama!city Eastern Hospital, Yokohama) OE-059 Endovascular Treatment for the Peripheral Artery Disease Reduces Blood Pressure and Improves a Prognosis Toshihiro Nozato(Department of Cardiology, NHO Disaster Medical Center, Tokyo) OE-060 Relationship between Ankle! brachial Index and the Complexity of Coronary Artery Disease in Peripheral Artery Disease Patients Jumpei Todoroki(Department of Cardiology, Syakaihoken Kobe Central Hospital, Kobe) 166 March 21 (Fri) AM Oral Presentation (English) 11 (HF) Room 14(Tokyo International Forum, Glass Building 7F, G701) 11:10−12:40 Autonomic Nervous System Chairpersons: Naoyuki Hasebe(Department of Internal Medicine, Cardiovascular, Respiratory and Neurology Division, Asahikawa Medical University, Asahikawa) Shin! ichi Ando(Sleep Apnea Center, Kyushu University Hospital, Fukuoka) OE-061 Vagal Stimulation Prevent Increment of Thirst in Rats with Myocardial Infarction Can Zheng(Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center, Osaka) OE-062 Baroreflex Activation Therapy in Wistar Kyoto and Spontaneously Hypertensive Rats―Responders and Non! responders? Michael Turner(Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center, Suita) OE-063 Carotid Body Denervation Prevents Pulmonary Edema and Left Ventricular Remodeling in Myocardial Infarction! induced Chronic Heart Failure Rats Akiko Nishizaki(Department of Cardiology, Kyushu University Graduate School of Medicine, Fukuoka) OE-064 Vagal Nerve Stimulation in Combination with Total! Support of Left Ventricular Assist Device Maximally Suppresses the Infarct Size in Ischemia Reperfusion Keita Saku(Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka) OE-065 Miso Soup Attenuates Salt! induced Sympathoexcitation via Inhibition of the Hypothalamic Mineralcorticoid Receptor Pathway in Pressure! overload Mice Koji Ito(Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka) OE-066 Cardiac Sympathetic Afferent Reflexes Stimulation Causes Salt Sensitivity via Upregulation of the Hypothalamic TNF! ENaCs! AVP Pathway Koji Ito(Department of Cardiology, Kyushu University Graduate School of Medical Sciences, Fukuoka) 167 March 21 AM March 21 (Fri) AM March 21 AM Oral Presentation (English) 12 (HF) Room 16(Tokyo International Forum, B2F, Seminar Room 2) 11:10−12:40 Valvular Heart Disease! Pericarditis! Cardiac Tumor 2 Chairpersons: Yoshiro Matsui(Department of Cardiovascular and Thoracic Surgery, Hokkaido University, Sapporo) Hitoshi Ogino(Department of Cardiovascular Surgery, Tokyo Medical University, Tokyo) OE-067 Cardiac Chamber and Tricuspid Annulus Relations in Tricuspid Regurgitation 3" D Computed Tomographic Analysis Naohiko Nemoto(Minneapolis Heart Institute and Foundation, USA) OE-068 Three Year Outcome of Patients Undergoing Percutaneous Mitral Valve Repair with MitraClip System Yohei Ohno(Department of Cardiology, Ferrarotto Hospital, University of Catania, Italy) OE-069 Enhanced Expression of Hemoglobin Scavenger Receptor and Heme Oxygenase" 1 is Associated with Aortic Valve Stenosis in Patients Undergoing Hemodialysis Kazuki Mizutani(Department of Cardiology, Osaka City General Hospital, Osaka) OE-070 Concentric Left Ventricular Hypertrophy for Paradoxical Low" flow Low" gradient Severe Aortic Stenosis: Results from Japanese Multicenter Aortic Stenosis Study, Retrospective Registry (JUST" R) Eiji Yamashita(Department of Cardiology, Gunma Prefectural Cardiovascular Center, Maebashi) OE-071 Paradoxical Low" Flow, Low" Gradient Severe Aortic Stenosis despite Preserved Ejection Fraction is Associated with Lower Aortic Valve Resistance Koichiro Takayama(Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka) OE-072 Prognostic Impact of Conversion to High Pressure Gradient in Patients with Paradoxical Low" Flow Low Pressure Gradient Severe Aortic Stenosis Eiji Yamashita(Department of Cardiology, Gunma Prefectural Cardiovascular Center, Maebashi) 168 March 21 (Fri) AM Oral Presentation (English) 13 (IM) Room 18(JP Tower, 4F, Hall 3) 11:10−12:40 Echocardiography (New Technology) Chairpersons: Satoshi Nakatani(Department of Health Sciences, Osaka University, Suita) Kazuaki Tanabe(Division of Cardiology, Shimane University, Izumo) OE-073 Prognostic Value of Left Ventricular Longitudinal Strain in Patients with Paradoxical Low! flow, Low! gradient Severe Aortic Stenosis and Preserved Ejection Fraction Kimi Sato(Cardiovascular Division, Faculty of Medicine, University of Tsukuba, Tsukuba) OE-074 Geometric Differences in Left Ventricular Outflow Tract with and without Upper Septal Hypertrophy in Aortic Stenosis: Three! dimensional Transesophageal Echocardiography Study Masaki Izumo(Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki) OE-075 Left Atrial Strain Provides Incremental Value for Stroke Risk Stratification over CHA2DS2! VASc Score and Prognostic Impact in Atrial Fibrillation Patients Masaru Obokata(Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, Maebashi) OE-076 Evaluation of Right Ventricular Hemodynamics by Two! dimensional Speckle Tracking in Patients with Chronic Pulmonary Thromboembolism Kenji Shiino(Division of Cardiology, Department of Internal Medicine, Fujita Health University School of Medicine, Toyoake) OE-077 Reliability of Aortic Stenosis Severity Classified by Three! Dimensional Echocardiography in Prediction of Cardiovascular Events Kimi Sato(Cardiovascular Division, Faculty of Medicine, University of Tsukuba, Tsukuba) OE-078 Noninvasive Estimation of Pulmonary Capillary Wedge Pressure in Various Cardiac Diseases Using Combination of Left Atrial Volume and Function Masanori Kawasaki(Department of Cardiology, Gifu University Graduate School of Medicine, Gifu) 169 March 21 AM March 21 (Fri) AM March 21 AM Oral Presentation (English) 14 (MD) Room 23(The Tokyo Chamber of Commerce and Industry, 4F, Meeting Room S) 11:10−12:40 Preventive Medicine! Epidemiology! Education 1 Chairpersons: Hisashi Adachi(Department of Community Medicine, Kurume University, Kurume) Hironori Saito(Department of Cardiology, Japanese Red Cross Okayama Hospital, Okayama) OE-079 Obesity Paradox in Japanese Acute Coronary Syndrome Patients after Percutaneous Coronary Intervention: An Observation Cohort Study Toru Oshima(Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo) OE-080 Obesity is Important Risk Factor for High Temperature Onset ST Elevation Myocardial Infarction Hiroki Usuku(Department of Cardiology, Kumamoto Chuo Hospital, Kumamoto) OE-081 24" hour Salt Intake Estimated by Spot Urine during 5 Years in the Japanese General Population Tomomi Hashimoto(Department of Internal Medicine, Enshu Hospital, Hamamatsu) OE-082 Stroke and Bleeding Events in Super" elderly Patients with Atrial Fibrillation: From One" year Follow" up of the Fushimi AF Registry Yugo Yamashita(Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto) OE-083 Relationship between Digit Ratio and Idiopathic Pulmonary Hypertension in Japanese Women Tsunehisa Yamamoto(Department of Cardiology, Keio University School of Medicine, Tokyo) OE-084 Epidemiological Analysis Helps to Formulate a Proper Health Policy Response in Kazakhstan Kairat Davletov(Republican Research Institute of Cardiology and Internal Diseases, Kazakhstan) 170 3月21日(金)午前 一般口述(日本語)1 (HF) 第 15 会場(東京国際フォーラム B2F セミナー室 1) 8:30−10:00 Exercise Test! Cardiac Rehabilitation 1 座長: 池田 久雄(久留米大学医療センター 循環器内科) 長山 雅俊(榊原記念病院 循環器内科) OJ-001 Brain" Derived Neurotrophic Factor Regulates Exercise Capacity and Mitochondrial Function in the Skeletal Muscle in Mice 髙田 真吾(北海道大学 循環病態内科学) OJ-002 Clinical Significance of a Spiral Phenomenon in the Plot of CO2 Output vs. O2 Uptake in Patients with Oscillatory Breathing 氷見 智子(心臓血管研究所 循環器内科) OJ-003 Cardiac Rehabilitation is Useful in Cardiac and Renal Function in CAD Patients with Concomitant Chronic Kidney Disease and Heart Failure 牛島 明子(東海大学八王子病院 循環器内科) OJ-004 Reduction in Microvascular Oxygen Partial Pressure during Exercise Affects as Factor to Enhance Skeletal Muscle Hypertrophy Signaling 小出 誠一郎(電気通信大学 先進理工学専攻) OJ-005 Prognostic Impact of Exercise Tolerance and Muscle Strength in Diabetic Patients after Off" pump Coronary Artery Bypass Grafting 横山 美帆(順天堂大学 循環器内科学) OJ-006 Combined Aerobic and Resistance Exercise Training Decrease Oxidative Stress by Augmenting Antioxidant Potential in Patients with Cardiovascular Disease 吉田 典子(久留米大学 健康・スポーツ科学センター) 171 March 21 AM 3月21日(金)午前 March 21 AM 一般口述(日本語)2 (P) 第 23 会場(東京商工会議所 4F 特別会議室 S) 8:30−10:00 Congenital Heart Disease! Kawasaki’s Disease 座長: 市田 蕗子(富山大学 小児科) 安河内 聰(長野県立こども病院 循環器小児科) OJ-007 Circumstances and Outcomes of Out" Of" Hospital Cardiac Arrest in Elementary and Middle School Students in the Era of Public" Access Defibrillation 三谷 義英(三重大学 小児科) OJ-008 Assessment of Genetic and Epigenetic Modifications in Hypoplatic Left Heart Syndrome by Disease" specific iPS Cells 小林 純子(岡山大学 心臓血管外科) OJ-009 Steroid Significantly Reduces Immunoglobulin Therapy Resistance in High Risk Kawasaki Disease Patients with Elevated BNP: A Sub" analysis of RAISE Study 深澤 隆治(日本医科大学 小児科) OJ-010 Long" term Outcome After Transcatheter Closure of Atrial Septal Defect in Adults: Influence of Procedure Ager on Clinical Outcome 髙谷 陽一(岡山大学 循環器内科学) OJ-011 Features of Atrial Septal Anatomy by Transesophageal Echo among Different Age Group: From CVIT Percutaneous ASD Closure Registry 原 英彦(東邦大学医療センター大橋病院 循環器内科) OJ-012 A Novel 4" D Image Reconstruction of Congenital Heart Disease Using Non" rigid Registration Technique of MSCT Images 白石 公(国立循環器病研究センター 小児循環器部) 172 3月21日(金)午前 一般口述(日本語)3 (A) 第 8 会場(東京国際フォーラム ガラス棟 4F G402) 11:10−12:40 Atrial Fibrillation! Anticoagulation 座長: 西 光弘(横浜南共済病院 循環器内科) 熊谷 浩司(群馬県立心臓血管センター 循環器内科) OJ-013 Feasibility and Safety of Periprocedural New Oral Anticoagulants in Patients Undergoing Catheter Ablation of Atrial Fibrillation 遠山 英子(福岡山王病院 ハートリズムセンター) OJ-014 Impact of Atrial Fibrillation and Oral Anticoagulation on Long" term Clinical Outcome in Elderly Patients Undergoing PCI 中井 健太郎(京都大学 循環器内科学) OJ-015 Predictors of Absence of LA" Thrombus in Patients with Atrial Fibrillation: Who Can Skip Transesophageal Echocardiography before Catheter Ablation? 中島 永美子(横須賀共済病院 循環器センター 内科) OJ-016 Relationship between Oral Anticoagulants and Dose of Heparin during Procedure in Patients Undergoing Catheter Ablation of Atrial Fibrillation 遠山 英子(福岡山王病院 ハートリズムセンター) OJ-017 Serum Anti" Xa Activity as a Practical Surveillance Method for New Oral Anti" coagulants 木村 雄弘(慶應義塾大学 循環器内科) OJ-018 Incidence of Silent Cerebral Thromboembolism in the Peri" procedural Period for Catheter Ablation of Atrial Fibrillation under Dabigatran Compared with Warfarin 今村 公威(大阪府済生会中津病院 循環器内科) 173 March 21 AM 3月21日(金)午前 March 21 AM 一般口述(日本語)4 (CAD) 第 12 会場(東京国際フォーラム ガラス棟 6F G602) 11:10−12:40 Coronary Revascularization! PCI (DES) 2 座長: 治田 精一(福山循環器病院) 上野 高史(久留米大学 循環器病センター) OJ-019 The Efficacy of Switching from DAPT to Clopidogrel Monotherapy at Chronic Phase after Everolimus" eluting Stent (EES) Implantation 矢野 秀樹(那須赤十字病院 循環器科) OJ-020 Late Phase Occurrence of Acute Coronary Syndrome and Neoatherosclerosis in Patients with Drug Eluting Stent; Insights from Optical Coherence Tomography 齋藤 裕(福岡市医師会成人病センター 循環器内科) OJ-021 Everolimus and Paclitaxel" Eluting Stents for Small Coronary Artery Diseases: Insight from the Two Years Results of PLUM and SACRA Registries 及川 裕二(心臓血管研究所 循環器内科) OJ-022 Clinical Performance of Newest 2" Link Promus Element DES―A Real World High Volume Analysis― 竹村 和紀(千葉西総合病院 心臓センター 循環器科) OJ-023 Impact of Diabetes Mellitus on Angiographic Outcomes in Patients with Different Drug" eluting Stents 羽原 誠二(倉敷中央病院 循環器内科) OJ-024 Long" term Clinical Outcomes Following PCI versus CABG for Ostial! Midshaft Lesions in Unprotected Left Main Coronary Artery from the DELTA Registry 長沼 亨(サンラファエロ病院) 174 3月21日(金)午前 一般口述(日本語)5 (HF) 第 15 会場(東京国際フォーラム B2F セミナー室 1) 11:10−12:40 Heart Failure (Pharmacology) 1 座長: 能澤 孝(富山大学 第二内科) 佐藤 幸人(兵庫県立尼崎病院 循環器内科) OJ-025 A Novel Selective EP4 Receptor Agonist Improves Cardiomyocyte Function by Inhibiting Ca2+ Leak through the Ryanodine Receptor in Failing Cardiomyocytes 村上 和華子(山口大学 器官病態内科学) OJ-026 RV Dysfunction Plays an Important Role in Predicting Non! response to Tolvaptan in Patients with Heart Failure with Reduced Ejection Fraction 岩橋 徳明(横浜市立大学市民総合医療センター 心臓血管センター) OJ-027 Tricuspid Annular Plane Systolic Excursion, Index of Right Ventricular Function, can Predict Responses to Tolvaptan in Congestive Heart Failure Patients 中野 雄介(愛知医科大学 循環器内科) OJ-028 Bisoprolol Might be Effective for Chronic Heart Failure with Low Ejection Fraction, Equivalently to Carvedilol 豊田 茂(獨協医科大学 心臓・血管内科) OJ-029 The Impact of β! blocker and Inhaled Tiotropium on Long! term Outcomes in Congestive Heart Failure Patients with Chronic Obstructive Pulmonary Disease 久保田 芳明(日本医科大学 循環器内科) OJ-030 Effects of Pitavastatin on Japanese Patients with Dilated Cardiomyopathy: A Subanalysis of the PEARL 水間 洋(千葉大学 循環器内科学) 175 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 1 (A) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 Atrial Fibrillation (Basic! Genetics) Chairperson: Junko Kurokawa(Department of Bio!informational Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo) PE-001 Heterogeneous Wall Thickness Provides a Substrate for Anchoring of I" shaped Filament Scroll Waves during Stretch" related Atrial Fibrillation Masatoshi Yamazaki(Research Institute of Environmental Medicine, Nagoya University, Nagoya) PE-002 The Relationship between Cardiac Vulnerability and Dynamics of Action Potential Duration Soichiro Yamashita(Department of Cardiovascular Medicine, Kobe University Graduate School of Medicine, Kobe) PE-003 Hsp90 Prevents Interaction between CHIP and HERG Proteins to Facilitate Maturation of Wild" type and Mutant HERG Proteins Pei Li Li(Division of Regenerative Medicine & Therapeutics, Tottori University, Yonago) PE-004 Genotype Specific Risk Marker of Torsades de Pointes in Long QT Syndrome Mutsuko Sangawa(Department of Cardiology, Okayama University School of Medicine, Okayama) PE-005 Relationship between Local Production of microRNA" 328 and Atrial Substrate Remodeling in Atrial Fibrillation Takeshi Soeki(Depatment of Cardiovascular Medicine, The University of Tokushima, Tokushima) PE-006 Mutations in SCN5A Associated with Monomorphic Ventricular Tachycardia, Conduction Disease, and J" Wave Syndrome Keiko Sonoda(Department of Cardiovascular Biology and Medicine, Niigata University School of Medical and Dental Sciences, Niigata) PE-007 High" Fat Diet Increases Vulnerability to Atrial Arrhythmia by Conduction Disturbance via microRNA Kentaro Takahashi(Department of Bio!informational Pharmacology, Tokyo Medical and Dental University, Tokyo) 176 March 21 (Fri) AM Poster Session (English) 2 (A) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 Atrial Fibrillation! Ablation 1 Chairperson: Shigeru Ikeguchi(Department of Cardiology, Shiga Medical Center for Adult, Moriyama) PE-008 Adequate Waiting Period to Check Pulmonary Vein Reconnection is Necessary after Circumferential Pulmonary Vein Isolation Kojiro Tanimoto(Department of Cardiology, National Hospital Organization Tokyo Medical Center, Tokyo) PE-009 Effect of Hybrid Therapy of Amiodarone and Bepridil on Sinus Rhythm Maintenance after Catheter Ablation for Long" standing Persistent Atrial Fibrillation Yoshiaki Yui(The Cardiovascular Division, Institute of Clinical Medicine, University of Tsukuba Graduate School of Comprehensive Human Sciences, Tsukuba) PE-010 Substrate Modification by Adding Ablation of Localized Complex Fractionated Electrograms after Stepwise Linear Ablation in Persistent Atrial Fibrillation Shiro Nakahara(Department of Cardiology, Dokkyo Medical University Koshigaya Hospital, Koshigaya) PE-011 Patients with Common Trunk of Pulmonary Vein Have Better Outcome of Catheter Ablation for Atrial Fibrillation Kenichi Tokutake(Department of Cardiology, The Jikei University School of Medicine, Tokyo) PE-012 Comparison of Anticoagulation Status between Warfarin and Dabigatran during Catheter Ablation for Atrial Fibrillation Keiichi Inada(Department of Cardiology, The Jikei University School of Medicine, Tokyo) PE-013 Response to Electrical Cardioversion and Efficacy of Catheter Ablation in Patients with Long" Standing Persistent Atrial Fibrillation Lasting#10 Years Atsushi Takahashi(Cardiovascular Center, Yokosuka Kyosai General Hospital, Yokosuka) PE-014 Pre" procedural Defibrillation Threshold and Cycle Length may Predict Early Recurrence after the First Pulmonary Vein Isolation for Persistent Atrial Fibrillation Kosuke Nakasuka(Division of Cardiology, Nagoya City East Medical Center, Nagoya) 177 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 3 (A) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 Atrial Fibrillation! Anticoagulation 1 Chairperson: Akira Nozaki(Division of Cardiology, Kanto Central Hospital, Tokyo) PE-015 A Japanese Multicenter Prospective Study of Rivaroxaban for Periprocedural Anticoagulation Therapy in Patients Undergoing Catheter Ablation of Paroxysmal Atrial Fibrillation Takeshi Sasaki(Heart Rhythm Center, Tokyo Medical and Dental University, Tokyo) PE-016 Comparisons of Bleeding and Thromboembolic Events with Dabigatran and Rivaroxaban in Japanese Patients with Atrial Fibrillation Takanobu Ozawa(Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo) PE-017 Efficacy and Safety of Ribaroxaban versus Warfarin as Uninterrupted Anticoagulation for Radiofrequency Catheter Ablation of Atrial Fibrillation Susumu Tao(Department of Cardiolovascular Medicine, Tokyo Medical and Dental University, Tokyo) PE-018 Anticoagulation and Platelet Inhibitions and the Risk of Bleeding and Stroke in Patients with Atrial Fibrillation: A National Cohort Kuo! Liong Chien(Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taiwan) PE-019 Novel Oral Anticoagulants Perioperative Therapy Requires Higher Dosages of Heparin during Atrial Fibrillation Ablation Compared with Warfarin Hirosuke Yamaji(Section of Heart Rhythm Center, Okayama Heart Clinic, Okayama) PE-020 Different Characteristics of Novel Oral Anticoagulants as Perioperative Therapy during Atrial Fibrillation Ablation Hirosuke Yamaji(Section of Heart Rhythm Center, Okayama Heart Clinic, Okayama) 178 March 21 (Fri) AM Poster Session (English) 4 (A) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 ECG Diagnosis! Pathophysiology Chairperson: Noriyuki Hayami(The Fourth Department of Internal Medicine, Mizonokuchi Hospital, Teikyo University, Kawasaki) PE-021 Relationship between J Wave and Ventricular Fibrillation Caused by Coronary Spastic Angina Akinori Matsumoto(Department of Internal Medicine, Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine, Kobe) PE-022 Relation with J Wave Syndrome and Vasospastic Angina Kenzaburo Nakajima(National Cerebral and Cardiovascular National Center, Osaka) PE-023 Clinical Impact of Ventricular Pacing on Long" term Prognosis in Patients with or without Structural Heart Disease Ayako Kamijima(Department of Cardiology, National Cerebral and Cardiovascular Center, Osaka) PE-024 Predictors of Premature Ventricular Complexes Induced Cardiomyopathy Originating from Left Sided Ventricle Jin Iwasawa(Division of Cardiology, Cardiovascular Center, Tsuchiura Kyodo Hospital, Tsuchiura) PE-025 The Impact of Non" invasive Positive Pressure Ventilation on Atrial Fibrillation Ablation in Patients with Sleep Apnea Ryohsuke Narui(Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo) PE-026 The Epidemiology and Diagnosis of Syncope Tatsuya Onuki(Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo) PE-027 Wireless Wearable ECG Monitoring System Using Electroconductive Textile Electrode―The Safety and Validity Yayoi Tetsuou! Tsukada(Department of Cardiovascular Medicine, Nippon Medical School, Tokyo) 179 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 5 (A) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 Supraventricular Tachycardia! Atrial Fibrillation 1 Chairperson: Tetsuyuki Manaka(Department of Cardiology, Tokyo Women’s Medical University, Tokyo) PE-028 High" Dominant Frequency Site is a Surrogate of a Rotor in Atrial Fibrillation Koji Kumagai(Division of Cardiology, Gunma Prefectural Cardiovascular Center, Maebashi) PE-029 Superior Vena Cava as the Substrate of Various Forms of Atrial Tachyarrhythmias: Consideration into the Mechanism and Tachycardia Circuit Miwa Ito(Department of Cardiovascular Medicine, Graduate School of Medicine, Kumamoto University, Kumamoto) PE-030 Bulge Just above Koch’s Triangle―Important Structural Findings Related to the Catheter Ablation of AVNRT― Osamu Igawa(Department of Internal Medicine and Cardiology, Tama!Nagayama Hospital, Nippon Medical School, Tama) PE-031 Efficacy of Contact Force" controlled Radiofrequency Catheter Ablation for Cavotricuspid Isthmus Takehito Sasaki(Department of Cardiology, Gunma Prefectural Cardiovascular Center, Maebashi) PE-032 Clinical Relationship between Reconnection of Pulmonary Vein and Recurrence of Atrial Fibrillation after Ethanol Infusion into Vein of Marshall Shinsuke Iwai(Division of Cardiology, Yokohama City Bay Red Cross Hospital, Yokohama) PE-033 Comparison between Long" term Clinical Efficacy and Conduction Block at Mitral Isthmus by Ethanol Infusion into Marshall Vein in Atrial Fibrillation Nobutaka Kato(Heart Center, Yokohama!city Bay Red Cross Hospital, Kanagawa) PE-034 Clinical Investigation of Ethanol Infusion into Marshall Vein in Terms of Creating Conduction Block at Mitral Isthmus Nobutaka Kato(Heart Center, Yokohama!city Bay Red Cross Hospital, Kanagawa) 180 March 21 (Fri) AM Poster Session (English) 6 (A) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 Ventricular Tachycardia! Ventricular Fibrillation 1 Chairperson: Ritsuko Kohno(The Second Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu) PE-035 Clinical Impact of Extremely Low" Dose Amiodarone on Lethal Ventricular Arrhythmia Yoshitaka Kimura(Department of Cardiology, National Cerebral and Cardiovascular Center, Suita) PE-036 Clinical Characteristics of J Wave in Patients with Brugada Syndrome Makoto Nakano(Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai) PE-037 Usefulness of a Newly Developed Synthesized 18" Lead Digital Electrocardiogram System in Detecting Right Ventricular Myocardial Infarction Shunji Fukunaga(Department of Cardiovascular Medicine, Toho University Faculty of Medicine, Tokyo) PE-038 Efficacy of Bepridil to Prevent Ventricular Fibrillation in Early Repolarization Syndrome Goro Katsuumi(Department of Cardiovascular Biology and Medicine Niigata University Graduate School of Medical and Dental Sciences, Niigata) PE-039 Distance between the His Bundle and the Septal Mitral Annulus Tatsuya Hayashi(National Hospital Organization Disaster Medical Center, Tokyo) PE-040 Electrophysiological and Pathological Characteristics of Monomorphic Ventricular Tachycardia Associated with Primary Cardiac Tumor Hiroshige Murata(Department of Cardiovascular Medicine, Nippon Medical School, Tokyo) PE-041 Early Detection of Ventricular Tachyarrhythmia Using Home Monitoring Prevents Electrical Storm in Patients with Defibrillator Kaoru Tanno(Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo) 181 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 7 (A) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 Ventricular Tachycardia! Ventricular Fibrillation 2 Chairperson: Yukio Sekiguchi(Cardiovascular Division, University of Tsukuba, Tsukuba) PE-042 Bipolar (Bi) and Sequential Unipolar (SeqU) Radiofrequency (RF) Ablation for the Treatment of Tachyarrhythmias Originating from Deep Intramyocardial Origin Masaomi Chinushi(Graduate School of Health Science, Niigata University School of Medicine, Niigata) PE-043 Characteristics of Induced Repetitive Ventricular Responses Degenerating into Ventricular Fibrillation in Brugada Syndrome and Ischemic Heart Disease Yuko Miki(Division of Cardiology, University of Tsukuba Hospital, Ibaraki) PE-044 Characteristics of the Patients with Idiopathic Ventricular Fibrillation (IVF) Complicated by Electrical Storms Yoshifusa Aizawa(Research and Development, Tachikawa Medical Center, Nagaoka) PE-045 Clinical and Electrocardiographic Characteristics of Idiopathic Ventricular Fibrillation Patients with Intraventricular Conduction Disturbance Shigetoshi Sakabe(Department of Cardiology, Ise Red Cross Hospital, Mie) PE-046 Prevalence and Significance of J" wave in Patients with Idiopathic Ventricular Arrhythmia Originating from Ventricular Outflow Tract Atsunobu Kasai(Department of Cardiology, Ise Red Cross Hospital, Ise) PE-047 Is the Earliest Activation Site Successful Ablation Site? Analysis on Ventricular Arrhythmias Originating Adjacent to the Left Aortic Sinus Cusp Keiichi Ashikaga(Department of Cardiology, Miyazaki Medical Association Hospital, Miyazaki) PE-048 Characteristics of Ventricular Tachycardia Originating above the Pulmonary Valve Kazuya Mizukami(Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo) 182 March 21 (Fri) AM Poster Session (English) 8 (CAD) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 ACS! AMI (Clinical! Diagnosis) 1 Chairperson: Atsushi Takagi(Department of Cardiology, Tokyo Women’s Medical University, Tokyo) PE-049 Usefulness of the Combination of GRACE and SYNTAX Scores for Predicting the Long" term Mortality of Patients with Acute Coronary Syndrome Atsushi Kikuchi(Department of Cardiology, Osaka General Medical Center, Osaka) PE-050 Detectable High" sensitivity Cardiac Troponin T Values are Useful for Evaluating Left Ventricular Function after 6 Months of Acute Myocardial Infarction Hirofumi Tomita(Department of Cardiology, Hirosaki University Graduate School of Medicine, Hirosaki) PE-051 Impact of Plaque Morphologies by Intravascular Ultrasound and Optical Coherence Tomography on Incomplete ST" Segment Resolution after Percutaneous Coronary Intervention Shigeki Kimura(Cardiovascular Center, Yokosuka Kyosai Hospital, Yokosuka) PE-052 Age"and Sex" Related Differences in Coronary Plaque High" Risk Features in Patients with Acute Coronary Syndrome Assessed by Computed Tomography Angiography Toshiro Kitagawa(Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical & Health Sciences, Hiroshima) PE-053 Vascular Endothelial Function of Elderly Women with Acute Coronary Syndrome Chisato Sato(Division of Cardiology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama) PE-054 Usefulness of Cardiac Troponin T Measurement as a Diagnostic Tool for Prognosis at Emergent Clinical Setting Noriko Kikuchi(Department of Cardiology, Tokyo Metropolitan Tama Medical Center, Tokyo) 183 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 9 (CAD) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 ACS! AMI (Clinical! Pathophysiology) 1 Chairperson: Satoru Otsuji(Department of Cardiology, Higashi Takarazuka Satoh Hospital, Takarazuka) PE-055 Clinical Characteristics Comparison between Patients Treated with and without β" blockers Following Acute Myocardial Infarction; Result of Q" TASK Multicenter Registry Takafumi Yamane(National Cerebral and Cardiovascular Center, Suita) PE-056 Acute Drop in Ambient Temperature and Future Cardiovascular Events among Patients with ST" Segment Elevation Myocardial Infarction Yasuhiro Uchida(Department of Cardiology, Yokkaichi Municipal Hospital, Yokkaichi) PE-057 The Prognostic Value of Transient and Persistent Worsening Renal Function (WRF) in Patients Underwent PCI with Acute Coronary Syndrome (ACS) Nobuhiro Murata(Department of Cardiology, The Cardiovascular Institute Hospital, Tokyo) PE-058 Investigations of Coronary Slow Flow Phenomenon in Acute Coronary Syndrome Using Optical Coherence Tomography and Pathological Examination Nehiro Kuriyama(Department of Cardiology, Miyazaki Medical Association Hospital, Miyazaki) PE-059 Platelet Microparticles Determine the Clinical Severity and the Extent of Myocardial Damage in Acute Coronary Syndrome Anggoro B. Hartopo(Universitas Gadjah Mada, Indonesia) PE-060 Predictors of In" Hospital Prognosis after Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction with High Killip Class Jun Shiraishi(Department of Cardiology, Kyoto First Red Cross Hospital, Kyoto) 184 March 21 (Fri) AM Poster Session (English) 10 (CAD) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 ACS! AMI (Clinical! Pathophysiology) 2 Chairperson: Takahiko Naruko(Department of Cardiology, Osaka City General Hospital, Osaka) PE-061 WRF and CKD Synergistically Deteriorated Long" Term Outcomes of ACS in Association with Enhanced Inflammatory Response and Left Ventricular Remodeling Hidehiro Kaneko(The Cardiovascular Institute, Tokyo) PE-062 Beta Blocker Use in Japanese Acute Coronary Syndrome Patients after Percutaneous Coronary Intervention Hidehiro Kaneko(The Cardiovascular Institute, Tokyo) PE-063 Different Kinetics of Postprandial Hyperlipidemia after High" Fat Meal between Patients with and without Coronary Artery Disease Akiyo Abe(Department of Cardiology, Iwate Prefectural Central Hospital, Iwate) PE-064 Impact of Gender Differences on Clinical Outcomes in Patients with Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention Masayuki Kawabe(Cardiovascular Division, Sogo Moriya Daiichi Hospital, Moriya) PE-065 Impact of the Platelet Reactivity after Clopidogrel on the Coronary Microcirculation in Patients with ST" elevation Myocardial Infarction Hidefumi Nakahashi(Department of Cardioligy, Fujisawa City Hospital, Fujisawa) PE-066 Platelet" Derived Growth Factor" BB as a Marker for Improvement of Cardiac Function after Coronary Thrombus Aspiration for ST" segment Elevation Myocardial Infarction Tomomi Koizumi(Department of Cardiovascular Medicine, Saitama International Medical Center, Hidaka) 185 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 11 (CAD) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 ACS! AMI (Clinical! Treatment) 1 Chairperson: Katsuro Kashima(Department of Cardiovascular Medicine, Ibusuki Medical Center, Ibusuki) PE-067 In" hospital Outcome of Myocardial Infarction at Hospitals with or without Emergent Cardiac Surgery Hideki Miyachi(Intensive and Cardiovascular Care Unit, Nippon Medical School Hospital, Tokyo) PE-068 Could Novel Bio" SYNTAX Score Predict Clinical Outcome in Patients Undergoing Primary Percutaneous Coronary Intervention with Acute Myocardial Infarction? Jang Hoon Lee(Kyungpook National University Hospital, Korea) PE-069 Low HDL Cholesterol Level on Admission was Predictor of In" hospital Mortality in Patients with Acute Coronary Syndrome Masaru Ishida(Department of Internal Medicine, Division of Cardiology, Iwate Medical University, Morioka) PE-070 Long" term Predictors of Mortality in STEMI Patient; Single Center Experience with 448 Cases Mitsuru Kahata(Cardiovascular Center, Sendai Kousei Hospital, Sendai) PE-071 Gender Differences in Mortality after ST" segment Elevation Acute Myocardial Infarction Saeko Takahashi(Department of Cardiology, Shonan Kamakura General Hospital, Kamakura) PE-072 Myocardial Salvage Effect of Remote Concomitant and Postconditioning Using Conventional Blood Pressure Cuff in Primary PCI for Acute Myocardial Infarction Woo! Young Chung(Boramae Medical Center, Korea) 186 March 21 (Fri) AM Poster Session (English) 12 (CAD) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 Atherosclerosis (Clinical! Diagnosis) 1 Chairperson: Takanori Yasu(Department of Cardiovascular Medicine, Dokkyo Medical University, Nikko Medical Center, Nikko) PE-073 Clinical Impact of Relationship between Ankle" Brachial Index Andcoronary Artery Lesion Complexity: A Subanalysis of the Shinano" registry Naoto Hashizume(Department of Cardiovascular Medicine, Shinshu University, Nagano) PE-074 Relationship between Non" HDL Cholesterol and Cardiovascular Mortality in Elderly General Japanese Population Noriko Inoue(Hiroshima A!Bomb Casualty Council Health Management and Promoting Center, Hiroshima) PE-075 Clinical Outcome Following Percutaneous Coronary Intervention for Patients with Polyvascular Atherosclerotic Disease Norihiko Kamioka(Department of Cardiology, Kokura Memorial Hospital, Kitakyushu) PE-076 Impact of Serum Uric Acid Levels on the Characteristics of Coronary Plaques Using Computed Tomography Angiography Taizo Kimura(Department of Cardiology, University of Tsukuba, Tsukuba) PE-077 The Ratio of EPA! AA Associates with Age of Patient Undergoing Coronary Intervention and Frequency of ST" segmental Elevation Myocardial Infarction Kentaro Jujo(Department of Cardiology, Nishiarai Heart Center Hospital, Tokyo) PE-078 Exercise" ABI with 3" minute Ankle Bending is Useful Method for Predicting PAD in Patients with Intermittent Claudication and Normal ABI Tsuyoshi Miyazawa(Hikone Municipal Hospital, Shiga) 187 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 13 (CAD) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 Coronary Revascularization! PCI (DES) 1 Chairperson: Yuji Sakanoue(Department of Cardiology, Cardiovascular Center, Higashisumiyoshi Morimoto Hospital, Osaka) PE-079 Efficacy and Sfety of Biodegradable Polymer Biolimus" Eluting Stent in Patients with Acute Coronary Syndrome: Comparison with Bare" Metal Stent Kensuke Ohe(Kokura Memorial Hospital, Kitakyusyu) PE-080 Impact of Total Everolimus" Eluting Stent Length on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention Dai Yamamoto(Department of Cardiology, Nagoya Central Hospital, Aichi) PE-081 The Impact of Hemodialysis and Insulin on 1" year Outcomes in Diabetic Patients Undergoing Percutaneous Coronary Intervention with Drug" eluting Stents Shouhei Kishi(Department of Cardiology, Tokyo Women’s Medical University, Tokyo) PE-082 One" Year Clinical Outcome with Biolimus" Eluting Stent in Chronic Total Occlusion: Comparison with Everolimus" Eluting Stent Takashi Morinaga(Department of Cardiology, Kokura Memorial Hospital, Kitakyusyu) PE-083 The Impact of Angiographic Peri" contrast Staining after Second Generation DES Implantation Takahiro Tokuda(Department of Cardiology, Saiseikai Yokohama City Eastern Hospital, Yokohama) PE-084 The Relation between Restenosis and the Changes of Vessel Angiographic Geometry after the Everolimus" eluting Stent Implantation in Angulated Lesions Toshiyuki Kimura(Department of Cardiology, Miyazaki Medical Association Hospital, Miyazaki) 188 March 21 (Fri) AM Poster Session (English) 14 (CAD) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 Coronary Revascularization!PCI (Restenosis!Others) 1 Chairperson: Isao Taguchi(Department of Cardiovascular Medicine, Dokkyo Medical University, Tochigi) PE-085 Incidence and Predictors of Bleeding Complications after Percutaneous Coronary Intervention: Comparison of Model Performance with Patients’ Characteristics and Technical Factors Yohei Numasawa(Department of Cardiology, Ashikaga Red Cross Hospital, Tochigi) PE-086 The Associasion of ADP Induced Platelet Aggregation and Stent Restenosis Yasuhiro Morita(Department of Cardiology, Ogaki Municipal Hospital, Ogaki) PE-087 Differences between Trans" femoral and Trans" non" femoral Percutaneous Coronary Intervention in Acute Coronary Syndrome: KICS Registry Masahide Nagano(Division of Cardiology, Cardiovascular Center, Saiseikai Kumamoto Hospital, Kumamoto) PE-088 Overexpansion Extends Stent Length: An Investigation Using a Blood Vessel Model Masahiro Yoshida(Department of Cardiology, Chukyo Hospital, Aichi) PE-089 Mid" term Clinical Outcomes after Polytetrafluoroethylene (PTFE)" covered Stent Implantation Hiroyoshi Kawamoto(Department of Cardiology Unit, New Tokyo Hospital, Chiba) PE-090 Unique “Obesity Paradox” in Japanese Patients with Coronary Artery Disease: A Report from a Multicenter Percutaneous Coronary Intervention Registry Yohei Numasawa(Department of Cardiology, Ashikaga Red Cross Hospital, Tochigi) PE-091 The Lesion Characteristics Associated with the Mismatch between Angiographic Severity of Stenosis and Fractional Flow Reserve Mayui Nakazawa(Department of Cardiology, Tokyo Women’s Medical University, Tokyo) 189 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 15 (CAD) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 Myocardial Ischemia! reperfusion (Basic) 1 Chairperson: Yasutomi Higashikuni(Department of Cardiovascular Medicine, The University of Tokyo, Tokyo) PE-092 FAMP, a Novel ApoA! I Mimetic Peptide Suppresses Myocardial Reperfusion Injury in Mice Yasunori Suematsu(Department of Cardiology, Fukuoka University Hospital, Fukuoka) PE-093 The Pivotal Role of mTORC2 and Ribosomal Protein S6 in Cardioprotective Signaling Toshiyuki Yano(Departmet of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University, Sapporo) PE-094 Intracellular Renin Preserves Mitochondrial Function and Protects Cardiomyocytes from Ischemic Injury in Diabetic Heart Daishi Nonaka(Department of Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu) PE-095 Nanoparticle! Mediated Targeting of Cyclosporine A to Mitochondria of Reperfused Myocardium Enhances Cardioprotection from Ischemia! Reperfusion Injury Gentaro Ikeda(Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Science, Fukuoka) 190 March 21 (Fri) AM Poster Session (English) 16 (HF) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 Cardiac Function (Clinical) 1 Chairperson: Toshiyuki Takahashi(Department of Cardiovascular Medicine, JR Tokyo General Hospital, Tokyo) PE-096 Clinical Impact of Myocardial Tissue Characterization on Response to Therapies in Nonischemic Dilated Cardiomyopathy Shunsuke Ishii(Department of Cardiovascular Medicine, Kitasato University School of Medicine, Kanagawa) PE-097 CHADS2 Score Reflect Left Atrium and Atrial Appendage Remodeling Intentionally Rather than CHA2DS2! VASc Score for the Prevention of Cerebral Infarction Masatsugu Ohe(Department of Cardiovascular Medicine, Kurume University, Kurume) PE-098 Reverse Left Atrial Remodeling and Strain after Successful Radiofrequency Catheter Ablation in Patients with Non! Paroxysmal Atrial Fibrillation Sou Takenaka(Department of Cardiology, Yokohama General Hospital, Yokohama) PE-099 Hemodynamic Superiority of Sutureless Repair Technique for Total Anomalous Pulmonary Venous Connection Manabu Nitta(Department of Pediatric Cardiology, Nagano Children’s Hospital, Nagano) PE-100 Evaluation of Global Circumferential Strain as Prognostic Marker after Administration of β! blockers in Patients with Dilated Cardiomyopathy Hidekazu Tanaka(Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe) PE-101 Diagnostic Performance of Left Ventricular Regional Wall Thickening by QGS in Patients with Dilated Cardiomyopathy Naoya Matsumoto(Department of Cardiology, Nihon University Surugadai Hospital, Tokyo) PE-102 Older Age and Women Influences Ventricular! Vascular Stiffening Independently of Coronary Artery Stenosis Kihei Yoneyama(Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine Hospital, Kawasaki) 191 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 17 (HF) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 Cardiomyopathy! Hypertrophy (Clinical) 1 Chairperson: Yoshikazu Yazaki(Division of Cardiovascular Medicine, Saku Central Hospital, Saku) PE-103 A New Insight for the Significance of Myofibroblasts in Human Dilated Cardiomyopathy: Relation with Left Ventricular Wall Stress Hideshi Okada(Department of Cardiology, Gifu University Graduate School of Medicine, Gifu) PE-104 Cardiac Magnetic Resonance can Detect Cardiac Involvement in Systemic Sclerosis Even in Patients without Any Abnormalities in Screening Tests Makoto Sano(Department of Cardiology, Hamamatsu University School of Medicine, Hamamatsu) PE-105 Prognostic Significance of the Change of Late Gadolinium Enhancement on Cardiovascular Magnetic Resonance in Non" ischemic Dilated Cardiomyopathy Takeru Nabeta(Department of Cardiovascular Madicine, Kitasato University School of Medicine, Kanagawa) PE-106 Comparative Study of Detecting Myocardial Inflammation in Cardiac Sarcoidosis Treated with Prednisolone Toshimi Koitabashi(Department of Cardiovascular Medicine, Kitasato University School of Medicine, Kanagawa) PE-107 Impact of Troponin" Gene Mutations and Renin" angiotension System Polymorphisms on Occurrence of Atrial Fibrillation in Hypertrophic Cardiomyopathy Akira Funada(Division of Cardiology, Kanazawa University, Kanazawa) PE-108 Prevalence of Myocardial Hypertrophy and Double Mutations in Sarcomere Gene Mutation Carriers Noboru Fujino(Division of Cardiovascular Medicine, Kanazawa University, Kanazawa) 192 March 21 (Fri) AM Poster Session (English) 18 (HF) Poster Session Room 2(Tokyo International Forum, A Block 4F, 5F, 6F, Foyer) 10:10−11:00 Cardiovascular Pharmacology (Clinical) 1 Chairperson: Masahiro Yasutake(Department of Integrated Medical Care and Health Science, Nippon Medical School, Tokyo) PE-109 Prognostic Impact of Beta! blocker in Patients with ST! segment Elevation Myocardial Infarction and High Value of Plasma Glucose on Admission Daisuke Abe(Department of Cardiology, Ibaraki Prefectural Central Hospital, Kasama) PE-110 Hypouricemic Effect of Angiotensin Receptor Blocker in Patients with High Risk Hypertension Nobuo Koshiji(Department of Cardiovascular Medicine, Dokkyo Medical University, Tochigi) PE-111 Clinical Effect of Eplerenone on Neurohumoral Factors and Lipid Metabolism in Mildly Symptomatic Heart Failure with Reduced Ejection Fraction Yohei Takayama(Department of Cardiology, Chubu Rosai Hospital, Nagoya) PE-112 High On! treatment Platelet Reactivity is Associated with a Risk of Restenosis in Patients with Coronary Stent Implantation Hiroya Matsumura(Department of Cardiovascular Medicine, Hiroshima University, Hiroshima) PE-113 Impact of Proton! pomp Inhibitors on On! treatment Platelet Reactivity in Patients with Dual Anti! platelet Therapy Sho Okamura(Department of Cardiovascular Medicine, Hiroshima Prefectural Hospital, Hiroshima) PE-114 Clinical Implication of the Monitoring of Rivaroxaban with an anti! Factor Xa Assay “Liquid Heparin” Kit Kozue Ikeda(Department of Cardiology, Shinoda General Hospital, Yamagata) 193 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 19 (HF) Poster Session Room 2(Tokyo International Forum, A Block 4F, 5F, 6F, Foyer) 10:10−11:00 Exercise Test! Cardiac Rehabilitation 1 Chairperson: Kazuto Omiya(Department of Cardiology, St. Marianna University Yokohama City Seibu Hospital, Yokohama) PE-115 Stretching Exercises Increase Exercise Capacity via Ameliorating Vascular Endothelial Function in Sedentary Chronic Heart Failure Patients with Implantable Cardioverter Defibrillator Michitaka Kato(Department of Rehabilitation, Shizuoka Medical Center, Shizuoka) PE-116 Respiratory Muscle Weakness is Associated with Exercise Intolerance in Elderly Patients with Heart Failure Kensaku Yamada(Tottori University, Cardiolovascular Medicine, Department of Molecular Medicine and Therapeutics, Yonago) PE-117 Impact of Aortic Stiffness on Exercise Intolerance in Patients with Reduced Left Ventricular Ejection Fraction Toshihiko Goto(Department of Cardio!Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya) PE-118 Determinants of Decrease in C" Reactive Protein through Cardiac Rehabilitation in Patients after Acute Myocardial Infarction Takahito Doi(National Cerebral and Cardiovascular Center, Suita) PE-119 Increases of Large HDL" Cholesterol Induced by Exercise" based Cardiac Rehabilitation is Strongly Associated with Improved Cardiopulmonary Fitness in Patients with ACS Yuya Yokota(Department of Medicine, Division of Cardiology, Showa University School of Medicine, Tokyo) PE-120 Cardiac Rehabilitation Improves Metabolic Chronotropic Relationship during Cardiopulmonary Exercise Test in Patients with Cardiovascular Diseases Nami Takano(Department of Cardiovascular Medicine, The University of Tokyo Hospital, Tokyo) PE-121 Effectiveness of Dobutamine Stress Echocardiography of Cardiac Risk in Patients Underlying Elective Non Cardiac Surgery with Pre Existing Cardiac Disease MD Saleh Uddin(Sher!e!Bangla Medical College, Bangladesh) 194 March 21 (Fri) AM Poster Session (English) 20 (HF) Poster Session Room 2(Tokyo International Forum, A Block 4F, 5F, 6F, Foyer) 10:10−11:00 Heart Failure (Diagnosis) 1 Chairperson: Nobuyuki Shiba(Cardiovascular Center, International University of Health and Welfare Hospital, Nasushiobara) PE-122 Can the Grip Strength Indicate Left Ventricular Diastolic Disorder? Yoshinobu Morikawa(Cardiovascular Medicine, Nara City Hospital, Nara) PE-123 Left Ventricular Ejection Fraction is Reduced in Acute Decompensated Heart Failure with Low Proportional Pulse Pressure at Hospital Arrival Nobuhiko Ueda(Senri Cardiovascular Center, Osaka Saiseikaisenri Hospital, Osaka) PE-124 Impact of Cardio! renal! anemia Continuum on Recurrent or Prolonged Hospitalization in Survived Patients with Acute Decompensated Heart Failure Shota Sasaki(Division of Cardiology, Hiroshima City Asa Hospital, Hiroshima) PE-125 Mixed Venous Oxygen Saturation but not Cardiac Index Predicts the Need for Inotropic Support in Decompensated Congestive Heart Failure Muneyoshi Tanimura(Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu) PE-126 Identification of Climatic Condition Associated with the Onset of Acute Heart Failure Syndrome: Insights from Acute Heart Failure Kyoto Registry Takuya Taniguchi(Department of Cardiovascular Medicine, North Medical Center, Kyoto Prefectural University of Medicine, Yosano! cho) PE-127 Conventional Surgical Risk Score of the Patients with Residual Functional Mitral Regurgitation after Treating Acute Decompensated Heart Failure Yuko Wada(Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka) 195 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 21 (HF) Poster Session Room 2(Tokyo International Forum, A Block 4F, 5F, 6F, Foyer) 10:10−11:00 Heart Failure (Laboratory! Biomarkers) 1 Chairperson: Jong! Dae Lee(Health Administration Center, University of Fukui, Fukui) PE-128 Salt Administration Stabilizes Hemodynamic Status Faster than Salt Restricted Therapy Independent of ADH in Acute Decompensated Heart Failure Yoshitaka Okuhara(Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya) PE-129 The Impact of Aldosterone Level of Salt Supplementation in Acute Decompensated Heart Failure Yoshitaka Okuhara(Division of Cardiovascular Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nisinomiya) PE-130 Blood Urea Nitrogen! Creatinine Ratio Predict Response to Tolvaptan in Hospitalized Decompensated Heart Failure Patients Dai Okayama(Department of Cardiology, Tokyo Women’s Medical University School of Medicine, Tokyo) PE-131 Renin" Angiotensin" Aldosterone System Attenuate the Clinical Effects of Tolvaptan; Vasopressin V2" receptor Antagonist on Patients with Acutely Decompensated Heart Failure Mahoto Kato(Division of Cardiovascular Medicine, Nihon University School of Medicine, Tokyo) PE-132 The Change of Blood Concentration of Tolvaptan During Hospitalization Course of Heart Failure with Fluid Overload, and Its Clinical Impact Mahoto Kato(Division of Cardiovascular Medicine, Nihon University School of Medicine, Tokyo) PE-133 Functional and Urinary Sodium and Potassium Aspect of Renal Sympathetic Nerve Denervation in Diabetic Ren" 2 Rats with Diastolic Heart Failure Masataka Watanabe(Department of Epidemiology and Preventive Medicine, Centre of Cardiovascular Research and Education in Therapeutics, Monash University, Australia) PE-134 ACE2 and Ang (1" 7) Concentration for Patients Urgently Hospitalized Due to Cardiovascular Disease Shinji Hisatake(Department of Cardiovascular Medicine, Toho University Omori Medical Center, Tokyo) 196 March 21 (Fri) AM Poster Session (English) 22 (HF) Poster Session Room 2(Tokyo International Forum, A Block 4F, 5F, 6F, Foyer) 10:10−11:00 Heart Failure (Laboratory! Biomarkers) 2 Chairperson: Makoto Kawai(Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo) PE-135 The Partial Pressure of End" tidal Carbon Dioxide Predicts the Complication of Secondary Pulmonary Hypertension in Patients with Advanced Heart Failure Osamu Seguchi(National Cerebral and Cardiovascular Center, Osaka) PE-136 Platelet Distribution Width as a Predictor of Cardiac Events in Patients with Chronic Heart Failure Due to Non" Ischemic Heart Disease Daisuke Kinoshita(Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata) PE-137 Comparisons of Prognostic Factors between Patients with Ischemic and Non" ischemic Etiology in Chronic Heart Failure Takamasa Satoh(Department of Cardiology and Hematology, Fukushima Medical University, Fukushima) PE-138 Prevalence and Characteristics of L" carnitine Insufficiency in Patients with Decompensated Heart Failure: Who may be Candidate for L" carnitine Supplementation? Yoshiharu Kinugasa(Division of Cardiovascular Medicine, Department of Molecular and Therapeutics, Faculty of Medicine, Tottori University, Yonago) PE-139 The Initial Anion Gap is a Predictor of In" Hospital Mortality in Severe Acute Heart Failure (Clinical Scenario 1" 3) Tomoharu Kawase(Department of Cardiology, Cardiovascular Center, Tsuchiya General Hospital, Hiroshima) PE-140 Thyroid Function and Outcome in Hospitalized Patients with Acute Decompensated Heart Failure Shohei Kataoka(Department of Cardiology, Tokyo Women’s Medical University, Tokyo) 197 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 23 (HF) Poster Session Room 2(Tokyo International Forum, A Block 4F, 5F, 6F, Foyer) 10:10−11:00 Heart Failure (Pharmacology) 1 Chairperson: Kazuhiko Hashimura(Hanwa Memorial Hospital, Cardiovascular Center, Osaka) PE-141 Combination Effects of Tolvaptan and Carperitide in Acute Decompensated Heart Failure Toru Dejima(Department of Cardiology, International Goodwill Hospital, Yokohama) PE-142 Combination of Tolvaptan and Furosemide Significantly Improves Survival Rate in Murine Heart Failure after Myocardial Infarction Compared with Tolvaptan Alone Akiyo Eguchi(Department of Internal Medicine, Cardiovascular Division, Hyogo College of Medicine, Hyogo) PE-143 Predicors of Mortality and Rehospitalization after Discharge in Patients Taking Tolvaptan for Long Periods Ruka Yoshida(Department of Cardiology, Ogaki Municipal Hospital, Ogaki) PE-144 Hemodynamic Predictors for Response to Tolvaptan Ruka Yoshida(Department of Cardiology, Ogaki Municipal Hospital, Ogaki) PE-145 Tolvaptan Improves Fluid Retention through Increasing Colloid Osmotic Pressure Yusuke Nakano(Department of Cardiology, Aichi Medical University, Aichi) PE-146 Comparison of Arginine Vasopressin V2 Antagonist with hANP on Fluid and Cardiac Function in Patients with Acute Decompensated Heart Failure Atsuyuki Wada(Division of Cardiology, Kusatsu General Hospital, Kusatsu) PE-147 Tolvaptan is Effective in Heart Failure Patients with Reduced Left Ventricular Systolic Function Satoshi Suzuki(Department of Cardiology and Hematology, Fukushima Medical University, Fukushima) 198 March 21 (Fri) AM Poster Session (English) 24 (HF) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 Infection! Inflammation! Immunity 1 Chairperson: Akihiro Nakagomi(Department of Internal Medicine and Cardiology, Tama!Nagayama Hospital, Nippon Medical School, Tokyo) PE-148 S100A8 Induction in Macrophages is Dependent on IL" 10 and Reactive Oxygen Species Yasumi Endoh(Department of Cardiology, Nippon Medical School, Tokyo) PE-149 Morning Pentraxin3 Levels Strongly Reflect Hypoxia" Induced Inflammation in Patients with Obstructive Sleep Apnea Yusuke Kobukai(Department of Cardiovascular and Respiratory Medicine, Akita University Graduate School of Medicine, Akita) PE-150 Inhibition of DPP" 4 Suppresses Monocyte Inflammatory Reaction and Attenuates the Formation of Abdominal Aortic Aneurysm in Mice Yoko Noda(Department of Cardiovascular Medicine, Okayama University, Okayama) PE-151 Interleukin" 6 can Play an Essential Role in Neovascularization after Limb Ischemia Makoto Shoji(Department of Medicine, Division of Cardiology, Showa University School of Medicine, Tokyo) PE-152 Impact of Circadian Variation on Inflammatory Response and Clinical Outcome after Reperfused Myocardial Infarction Atsushi Anzai(Department of Cardiology, Keio University School of Medicine, Tokyo) PE-153 Mortality Risk Factors in Chronic Kidney Disease Patients with Infective Endocarditis Jun Nakazato(Division of Cardiology, Okinawa Chubu Hospital, Uruma) 199 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 25 (HT) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 Hypertension (Basic) 1 Chairperson: Yasuaki Dohi(Cardio!Renal Medicine and Hypertension, Nagoya City University, Nagoya) PE-154 Decreases in T! Regulatory Lymphocytes Precede Blood Pressure Elevation in Stroke! Prone Spontaneously Hypertensive Rats Masato Katsuki(Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka) PE-155 Excessive Nitric Oxide Diminished the Ability of ARB! induced Blood Pressure Lowering in Mice Model of Ang II! induced High Blood Pressure Eiji Yahiro(Department of Cardiology, Fukuoka University School of Medicine, Fukuoka) PE-156 Inhibitory Action on Sympathetic Preganglionic Neurons Yoshino Minoura(Department of Cardiology, Showa University School of Medicine, Tokyo) PE-157 The Role of Interleukin! 1 Receptor Antagonist in Angiotensin II! induced Hypertension and Renal Damages Sarasa Isobe(Department of Internal Medicine, Japan Self Defense Forces Sapporo Hospital, Sapporo) PE-158 Native and Modified High! density Lipoprotein! induced Aldosterone Synthesis were Decreased by ApolipoproteinA! I Mimetic Peptide Yasunori Suematsu(Department of Cardiology, Fukuoka University School of Medicine, Fukuoka) 200 March 21 (Fri) AM Poster Session (English) 26 (HT) Poster Session Room 1(Tokyo International Forum, B2F, Exhibition Hall) 10:10−11:00 Hypertension (Clinical) 1 Chairperson: Johji Kato(Frontier Science Research Center, University of Miyazaki, Miyazaki) PE-159 Vascular Function and Atherosclerosis is Similar in Patient with Idiopathic Hypealdosteronism and Essential Hypetension Yuichi Fujii(Department of Cardiovascular Medicine, Hiroshima General Hospital of West Japan Railway Company, Hiroshima) PE-160 Effect of Long! Term Administration of Olmesartan and Azelnidipine Combination Therapy Compared to Olmesartan Monotherapy on Insulin Resistance in Hypertension Mitsuru Masaki(Department of Cardiology, Hyogo College of Medicine, Nishinomiya) PE-161 Effect of Central Adiposity on the Progression of Arterial Stiffening and Central Hemodynamic Abnormalities Kazutaka Kimura(Department of Cardiology, Tokyo Medical University Ibaraki Medical Center, Ibaraki) PE-162 Association of Impaired Left Ventricular Longitudinal Shortening in Hypertension; the Role of Cardiac Deformation by Ventriculography in Cardiac Catheterization Laboratory Shingo Kuwata(Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine Hospital, Kawasaki) PE-163 Association between Oral Health Disorders and Risk of Hypertension in a Japanese Urban Population: The Suita Study Yoshio Iwashima(Divisions of Hypertension and Nephrology, Department of Medicine, National Cerebral and Cardiovascular Center, Osaka) PE-164 Association between Arterial Stiffness and Variability in Systolic Blood Pressure during a Single Clinic Visit in Treated Hypertensive Patients Hisashi Masugata(Department of Integrated Medicine, Kagawa University, Kagawa) PE-165 Age Dependency of Ankle, Brachial and Central Systolic Blood Pressure: A Cross! sectional Observation Study Akio Ishida(Department of Cardiovascular Medicine, Nephrology and Neurology, Faculty of Medicine, University of the Ryukyus, Okinawa) 201 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 27 (IM) Poster Session Room 3(Tokyo International Forum, Glass Building 7F, Lounge) 10:10−11:00 CT! MRI (Coronary! Vascular) 1 Chairperson: Akira Sato(Cardiovascular Division, University of Tsukuba, Tsukuba) PE-166 21 Previously Performed Coronary Computed Tomography Images before Onset of Acute Coronary Syndrome Masaaki Okutsu(Department of Cardiology, Nozaki Tokushukai Hospital, Osaka) PE-167 Atherosclerosis in Descending Thoracic Aorta might be Independently Related with Coronary Atherosclerosis on Computed Tomography Coronary Angiography Seung Woon Jun(Daegu Catholic University Medical Center, Korea) PE-168 Prevalence of Subclinical Coronary Aartery Disease in Ischemic Stroke Patients Koichiro Iwasaki(Department of Cardiology, Okayama Kyokuto Hospital, Okayama) PE-169 Fusion Imaging with Coronary MRI and Myocardial Perfusion Yasuyo Taniguchi(Department of Cardiology, Himeji Cardiovascular Center, Himeji) PE-170 Impact of Coronary Plaque Composition by 320" slice Computed Tomography on Slow Flow during PCI in Non" ST Elevation Acute Coronary Syndrome Makoto Araki(Division of Cardiology, Cardiovascular Center, Tsuchiura Kyodo Hospital, Tsuchiura) PE-171 Effects of Pitavastatin or Rosuvastatin on Characteristics of Coronary Plaques by Cardiac Magnetic Resonance Hiroshi Ueda(Department of Cardiology, Takai Hospital, Tenri) 202 March 21 (Fri) AM Poster Session (English) 28 (IM) Poster Session Room 3(Tokyo International Forum, Glass Building 7F, Lounge) 10:10−11:00 Echocardiography (New Technology) Chairperson: Chisato Izumi(Department of Cardiology, Tenri Hospital, Tenri) PE-172 A Novel Echocardiographic Parameter for the Electrical Remodeling can Predict the Recurrence of Atrial Fibrillation after Catheter Ablation Keiko Fukushima(Department of Cardiology, Tokyo Womens Medical University, Tokyo) PE-173 Single Beat Three! Dimensional Echocardiography for the Assessment of Right Ventricular Volume for Adult Patients with Tetralogy of Fallot Kanako Kishiki(Department of Pediatric Cardiology, Sakakibara Heart Institute, Tokyo) PE-174 Validity of Automated Global Strain Measurements with Low! dose Dobutamine Stress for the Assessment of Myocardial Viability after Acute Myocardial Infarction Eiichi Hyodo(Division of Cardiology, Nishinomiya Watanabe Cardiovascular Center, Nishinomiya) PE-175 Prediction of Aortic Stenosis! related Events in Patients with Systolic Ejection Murmur Using Pocket! sized Echocardiography Atsuko Furukawa(Department of Cardiology, Osaka City General Hospital, Osaka) PE-176 Morphological Change of Mitral Valve Complex during Off! pump Coronary Artery Bypass Surgery by Three! dimensional Echocardiography in Porcine Model Takashi Igarashi(Department of Cardiovascular Surgery, Fukushima Medical University, Fukushima) PE-177 Assessment of Right Ventricular Contractile Function Using Tissue Motion Annular Displacement (TMAD) Yuko Yamanaka(Department of Cardiology Sakurabshi!Watanabe Hospital, Osaka) PE-178 Association between Left Ventricular Twisting Motion and LV Dyssynchrony in 3! Dimentional Speckle Tracking Imaging Shohei Fujiwara(Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Hyogo) 203 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 29 (MD) Poster Session Room 4(The Tokyo Chamber of Commerce and Industry, 4F, Meeting Room AB) 10:10−11:00 Diabetes 1 Chairperson: Ryuko Anzawa(Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo) PE-179 The Influence of the Glucose Flucuation and Haptoglobin Phenotypes on Macroangiopathy Takao Sato(Toyama Rousai Hospital, Uozu) PE-180 Association between Prior Aspirin Use and Optical Coherence Tomography Findings in Diabetes Mellitus Patients Presenting with First Acute Coronary Events Tetsumin Lee(Division of Cardiology, Cardiovascular Center, Tsuchiura Kyodo Hospital, Tsuchiura) PE-181 Impact of Diabetic Retinopathy on Late Cardiac Events after Percutaneous Coronary Intervention Akihito Tanaka(Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya) PE-182 The Association with Glycemic Variability and Albuminuria in Patients with Acute Myocardial Infarction Shunsuke Kataoka(Yokohama City University Medical Center, Yokohama) PE-183 Impact of Loss of Function Variant of Betatrophin on Advanced Coronary Artery Disease among Diabetic Patients in Japan Atsushi Nohara(Department of Lipidology, Kanazawa University Graduate School of Medical Sciences, Kanazawa) PE-184 Diabetes Mellitus may not be a Risk of Stroke in Japanese Patients with Atrial Fibrillation: From the Fushimi AF Registry Mitsuru Ishii(Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto) PE-185 Obesity Paradox in Re! Admission and Absence of Obesity Paradox in Mortality of Diabetic Patients with Acutely Decompensated Heart Failure Kazumasa Harada(Tokyo CCU Network Scientific Committee, Division of Cardiology, Tokyo Metropolitan Geriatric Hospital, Tokyo) 204 March 21 (Fri) AM Poster Session (English) 30 (MD) Poster Session Room 4(The Tokyo Chamber of Commerce and Industry, 4F, Meeting Room AB) 10:10−11:00 Preventive Medicine! Epidemiology! Education 1 Chairperson: Masaki Ohsawa(Department of Hygiene and Preventive Medicine, Iwate Medical University, Yahaba) PE-186 Importance of Antioxidant Capacity in Predicting Long" term Outcomes Following Acute Myocardial Infarction: A Subanalysis of the ALPS" AMI Study Naoyuki Abe(Department of Cardiology, Shinshu University School of Medicine, Matsumoto) PE-187 The Association of Epicardial Fat Thickness and Coronary Artery Calcification, Blood Pressure Status in Non" hypertensive Individuals Byung Jin Kim(Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Korea) PE-188 Epicardial Fat Thickness is Associated with Coronary Artery Calcification Byung Jin Kim(Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Korea) PE-189 Urine Albumin Creatinine Ratio could Predict Cardiac Event in Non" diabetes Seung Pyo Hong(Daegu Catholic University Medical Center, Korea) PE-190 Plasma Brain Natriuretic Peptide Level is Independently Associated with 3" months Mortality in Patients Hospitalized with Pneumonia Shougo Murakami(Department of Cardiovascular Medicine, Soseikai General Hospital, Kyoto) PE-191 Insufficient Administration of Cardioprotective Agents for Secondary Prevention of Cardiovascular Events after Percutaneous Coronary Intervention: A Subanalysis of the Shinano" registry Takashi Miura(Department of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto) PE-192 Clinical Application of Heart Rate Variability in Fetuses Assessed by Magnetocardiography Yoshiaki Kato(Department of Child Health, University of Tsukuba, Tsukuba) 205 March 21 AM March 21 (Fri) AM March 21 AM Poster Session (English) 31 (O) Poster Session Room 4(The Tokyo Chamber of Commerce and Industry, 4F, Meeting Room AB) 10:10−11:00 Cerebrovascular Circulation! Stroke 1 Chairperson: Yusuke Ohya(Department of Cardiovascular Medicine, Nephrology and Neurology, University of the Ryukyus, Okinawa) PE-193 Compound K811 Prevents Vascular Cognitive Decline by Inhibiting Apoptosis Signal" Regulating Kinase" 1 Kensuke Toyama(Department of Pharmacology and Molecular Therapeutics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto) PE-194 The Relationship between Left Atrial Enlargement and Incidence of Stroke in Patients with Atrial Fibrillation: From the Fushimi AF Registry Yasuhiro Hamatani(Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto) PE-195 Apop Inhibition Reduces Inflammation after Cerebral Ischemia Osamu Yasuda(Department of Cardiovascular Clinical and Translational Research, Kumamoto University Hospital, Kumamoto) PE-196 Catheterization" Related Cerebral Infarction Evaluated by Diffusion" Weighted Magnetic Resonance Imaging was not Reduced despite Asymptomatic in High" risk Patients Yusuke Morita(Cardiovascular Center, The Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka) PE-197 Plasma Thrombin Cleaved Osteopontin would be a Marker of Acute Athero" thrombotic Ischemic Stroke Mie Kurata(Experimental Cardiology, Erasmus Medical Center, the Netherlands) 206 3月21日(金)午前 ポスターセッション(日本語)1 (CAD) ポスター会場 1(東京国際フォーラム B2F 展示ホール) 10:10−11:00 Coronary Revascularization!PCI (Restenosis!Others) 2 座長: 川崎 雅規(岐阜大学 循環病態学) PJ-001 Vein Graft Failure and Secondary Revascularization: Comparison of PCI in Saphenous Vein Graft and Native Coronary Artery 宮城 唯良(国立循環器病研究センター 心臓血管内科) PJ-002 Clinical Utility of Optical Coherence Tomography Criteria for the Determination of Optimal Stent Edge Positions in Percutaneous Coronary Intervention 吉川 俊治(東京医科歯科大学 循環制御内科学) PJ-003 Increase of Oxidized LDL Cholesterol is Independently Associated with the Periprocedual Myocardial Damage during Percutaneous Coronary Intervention 藤村 光則(高松市民病院 循環器科) PJ-004 The Discordance of Frequency and Clinical Outcome of Stent Fracture: Everolimus" Eluting Stent versus Sirolimus" Eluting Stent 須賀 一将(トヨタ記念病院 循環器科) PJ-005 Insulin Resistance is a Predictor of Late Catch" up Phenomenon after Drug" Eluting Stent Implantation 小松 禎子(獨協医科大学越谷病院 循環器内科) PJ-006 Prognostic Value of Clinical SYNTAX Score for Risk Assessment in Patients with Left Main Trunk Disease 水上 浩行(福島県立医科大学 循環器・血液内科学講座) PJ-007 The Determination Factors of Impaired Flow after Re" PCI to the In" stent Restenosis (ISR) Lesions 小岩屋 宏(宮崎市郡医師会病院 循環器内科) 207 March 21 AM 3月21日(金)午前 March 21 AM ポスターセッション(日本語)2 (CAD) ポスター会場 1(東京国際フォーラム B2F 展示ホール) 10:10−11:00 Thromboembolism! Antithrombotic Therapy! Thrombolysis 1 座長: 大嶋 秀一(熊本中央病院 循環器科) PJ-008 Relationship between CHA2DS2" VASc Scores and Left Atrial Thrombus in Patients with Nonvalvular Atrial Fibrillation 山田 麻里可(聖マリアンナ医科大学 循環器内科) PJ-009 What is Residual Risk Factors of Thromboembolisms in Low CHADS2 Score Patients? 吉崎 徹(静岡市立静岡病院 循環器内科) PJ-010 Efficacy and Safety of Low" dose Tissue Plasminogen Activator Therapy for Cardio Pulmonary Arrest! Collapse Patients with Acute Pulmonary Embolism 小林 一士(平塚共済病院 心臓センター 循環器科) PJ-011 Middle" term Course after Retrievable Inferior Vena Cava Filter Placement for Venous Thromboembolism Patients with or without Malignancy 明城 正博(東京大学 循環器内科) PJ-012 Underuse of Warfarin Therapy is Improved by New Oral Antithrombotic Agents in Clinical Practice 福田 信之(済生会富山病院 内科) PJ-013 Increased Serum Uric Acid Level is a Predictor of Thromboembolic Risk in Patients with Nonvalvular Atrial Fibrillation at Low" moderate Risk 沼 哲之(富山大学 第二内科) PJ-014 Coagulation Assay Measurements for Novel Oral Anticoagulants 中嶋 民夫(大和橿原病院 内科) 208 3月21日(金)午前 ポスターセッション(日本語)3 (HF) ポスター会場 2(東京国際フォーラム A ブロック 4F, 5F, 6F ホワイエ) 10:10−11:00 Heart Failure (Non! pharmacology) 1 座長: 渡邊 千秋(武田総合病院 循環器内科) PJ-015 Association between Cheyne! Stokes Respiration and Cardiac Sympathetic Nerve Activity in Patients with Systolic Heart Failure 浅井 光俊(大阪警察病院 心臓センター 循環器科) PJ-016 Adaptive Servo! Ventilation Reduces the Rate of Endotracheal Intubation in Patients with Acute Cardiogenic Pulmonary Edema 木下 将城(愛媛県立中央病院 循環器内科) PJ-017 Effectiveness of Adaptive Servo! Ventilator in Acute Heart Failure Patients: Retrospective Analysis 齊藤 伸介(市立砺波総合病院 循環器科) PJ-018 IT Networking System for Patient Care in Kameda Medical Center 鈴木 誠(亀田総合病院 循環器内科) PJ-019 Meteorological Factors Affecting Epidemiology of Heart Failure 大矢 俊之(日本大学 循環器内科) PJ-020 Chronic Obstructive Pulmonary Disease in Acute Decompensated Heart Failure: Prevalence and Therapeutic Implications 川上 利香(奈良県立医科大学 第一内科) PJ-021 Hemodynamic Effects on Left Ventricular Pressure durig Intraaortic Balloon Pumping 村瀬 洋介(公立陶生病院 循環器科) 209 March 21 AM 3月21日(金)午前 March 21 AM ポスターセッション(日本語)4 (IM) ポスター会場 3(東京国際フォーラム ガラス棟 7F ラウンジ) 10:10−11:00 CT! MRI (New Technology) 座長: 中尾 浩一(済生会熊本病院心臓血管センター 循環器内科) PJ-022 Impact of Assessment for Aortic Valve by Using Four" dimension Multidetector Computed Tomography in Patients with Severe Aortic Stenosis 酒井 浩多(榊原記念病院 循環器内科) PJ-023 The Determination of Best Strain Cut" off Value for Detecting Myocardial Fibrosis Assessed by Feature Tracking Analysis with Cardiac Magnetic Resonance 芳谷 英俊(産業医科大学 循環器・腎臓内科) PJ-024 Decreased Aortic Annulus Elasticity Obtained by Four" dimension Multidetector Computed Tomography is Associated with Severe Aortic Valve Calcification 田村 晴俊(榊原記念病院 循環器内科) PJ-025 Novel Quantification Method of Myocardium" mass" at" Risk Utilizing Multidetector" Row Computed Tomography; Validation with Angiographic Score in Patients with Coronary Artery Disease 井手 盛子(大阪大学 循環器内科学) PJ-026 Relationship between Quantitative T2 Mapping in Cardiac Magnetic Resonance Imaging and Washout of 99mTc" tetrofosmin in Patients with Dilated Cardiomyopathy 茂 真由美(神戸大学 循環呼吸器病態学) PJ-027 Evaluation of Left Atrium Wall Motion by Using 5D" Computed Tomography 歌野原 祐子(榊原記念病院 循環器内科) 210 3月21日(金)午前 ポスターセッション(日本語)5 (IM) ポスター会場 3(東京国際フォーラム ガラス棟 7F ラウンジ) 10:10−11:00 Echocardiography! Vascular Ultrasonography 1 座長: 高野 真澄(福島県立医科大学 集中治療部) PJ-028 Geometric Impact of the Novel Papillary Heads Optimization Surgery for Functional Mitral Regurgitation; Real" Time Three Dimensional Echocardiographic Study 戸井田 玲子(宮崎大学 内科学講座循環体液制御学分野) PJ-029 Impact of Right Ventricular Function on Exercise Capacity in Patients with Asymptomatic Severe Mitral Regurgitation 上嶋 亮(聖マリアンナ医科大学 循環器内科) PJ-030 Severity of Obstructive Sleep Apnea Syndrome is Associated with Left and Right Ventricular Dysfunction Demonstrated by the 2D" speckle Tracking Imaging 松井 泰樹(昭和大学 循環器内科学部門) PJ-031 Left Atrial Booster" Pump Function as a Predictive Parameter for New" Onset Postoperative Atrial Fibrillation in Patients with Aortic Stenosis 今西 純一(神戸大学 循環器内科学分野) PJ-032 Echocardiographic Assessment of Right Ventricular Systolic Function in Heart Failure Patients after Left Ventricular Assist Device Implantation 村井 大輔(北海道大学 循環病態内科学) PJ-033 Impact of Age on Diastolic Function and Left Atrial Volume and Function in Normal Subjects Assessed by Speckle Tracking Echocardiography 金田 真由美(岐阜県総合医療センター 循環器科) 211 March 21 AM 3月21日(金)午前 March 21 AM ポスターセッション(日本語)6 (MD) ポスター会場 4(東京商工会議所 4F 特別会議室 AB) 10:10−11:00 Smoking! Alcohol! Life Style 座長: 辻 久子(守口市市民保健センター) PJ-034 Impact of Smoking Habit on Coronary Plaque Vulnerability Assessed by Integrated Backscatter Intravascular Ultrasound 岩田 敦(福岡大学 心臓血管内科学) PJ-035 Eight Weeks Smoking Cessation Improves Vascular Function and Increases Circulating MicroRNA" 126 in Middle" Aged Habitual Smokers 杉浦 知範(名古屋市立大学 心臓・腎高血圧内科学) PJ-036 The Prevalence of Cardiovascular Risk Factors between Smokers and Non" Smokers 桒原 政成(虎の門病院 循環器センター 内科) PJ-037 Acute Coronary Syndrome in Young Adults―Clinical Background, Onset Form and Prognosis― 比企 優(順天堂大学 循環器内科学) PJ-038 Cigarette Smoking is Associated with Electrocardiogram Abnormalities in Japanese Population 菅野 道貴(国際医療福祉大学病院 循環器センター) PJ-039 Small Intestine, but not Intestinal Lymphocyte, was Responsible for High Fat Diet" induced Upregulation of DPP" 4 豊崎 美紅(東京医科歯科大学 先進倫理医科学) 212 3月21日(金)午前 チーム医療セッション 教育講演 1 (IM) 第 17 会場(JP タワー 4F ホール 1! 2) 8:30−10:00 放射線による人体への影響 座長: 江口 陽一(山形大学 放射線部) 中川 義久(天理よろず相談所病院 循環器内科) CE1-1 低線量放射線被ばくに伴う発がんリスク 島田 義也(放射線医学総合研究所 医療被ばく研究プロジェクト) CE1-2 循環器領域の放射線防護に関する ICRP(国際放射線防護委員 会)等の最近の動向∼従事者と患者における放射線防護∼ 菊地 透(自治医科大学RIセンター) CE1-3 心カテ室における放射線防護 粟井 一夫(榊原記念病院 放射線科) 213 March 21 AM 3月21日(金)午前 March 21 AM チーム医療セッション シンポジウム 1 [日本遠隔医療学会 ―日本循環器学会ジョイントシンポジウム](O) 第 17 会場(JP タワー 4F ホール 1! 2) 11:10−12:40 遠隔モニタリングをいかにチームで活用するか? 座長: 酒巻 哲夫(高崎市医師会看護専門学校) 三浦 稚郁子(榊原記念病院 看護部) CS1-1 IT を活用した在宅 PT!INR 自己測定と共同薬物治療管理システム ∼ワルファリンと相互作用を有する薬剤との併用薬物療法支援∼ 山村 恵子(愛知学院大学 薬学部 臨床薬剤学) CS1-2 岡山大学病院における遠隔モニタリングチームの活動 竹中 祐樹(岡山大学 循環器内科学) CS1-3 遠隔モニタリングシステムの現状と課題 前田 友未(榊原記念病院 看護部) CS1-4 慢性心不全における遠隔モニタリングの役割:多職種協働と行動 変容 琴岡 憲彦(佐賀大学 先端心臓病学) CS1-5 プレホスピタルにおける遠隔モニタリングとチーム医療: 12 誘導心電図伝送の活用 野々木 宏(静岡県立総合病院) 214 3月21日(金)午前 チーム医療セッション 一般演題(ポスター)1 (O) ポスター会場 2(東京国際フォーラム A ブロック 4F, 5F, 6F ホワイエ) 10:10−11:00 看護(急性期)1 座長: 高田 弥寿子(国立循環器病研究センター 看護部) CP-001 急性心筋梗塞発症 12 時間以上で PCI を施行した患者背景とその 院内予後について 齋藤 五香(済生会宇都宮病院) CP-002 慢性維持透析に合併した下肢閉塞性動脈硬化症患者における 入院後急変予測因子の検討 藤江 亜矢子(関西労災病院) CP-003 当院における Door! to! balloom Time の現状と短縮への試み 内海 由加里(KKR高松病院 看護部) CP-004 当院の HCU におけるせん妄看護に関する現状調査 沖田 隆子(KKR高松病院 看護部) CP-005 ICD 植込み術後の不安に対する精神的サポートを考えて ∼一事例の振り返りとアンケート調査から∼ 林田 喜世(天理よろづ相談所病院 循環器内科) CP-006 せん妄アセスメントスコアシート改訂後の評価と検討 千葉 香苗(京都府立医科大学 高度心臓血管センター) チーム医療セッション 一般演題(ポスター)2 (O) ポスター会場 2(東京国際フォーラム A ブロック 4F, 5F, 6F ホワイエ) 10:10−11:00 リハビリテーション・身体活動 1 座長: 井澤 和大(聖マリアンナ医科大学 リハビリテーション部) CP-007 演題取下げ CP-008 高齢心不全患者の 6 分間歩行距離は心不全増悪による再入院と 関連する 中島 宏樹(一宮市立市民病院 リハビリテーション室) CP-009 PCPS による下肢機能障害の検討 小園井 祥恵(茨城県立中央病院 リハビリテーション科) CP-010 植込型補助人工心臓装着患者の運動能力の推移∼術前から術後 自宅退院後 6 ヶ月までの経過∼ 天尾 理恵(東京大学 リハビリテーション部) 215 March 21 AM 3月21日(金)午前 March 21 AM CP-011 運動中における心収縮性の測定法∼Wave Intensity の応用∼ 田中 みどり(姫路獨協大学 医療保健学部) CP-012 自己管理能力向上に影響を与える潜在的な構成因子の検討 鈴木 貴広(手稲渓仁会病院 リハビリテーション部) CP-013 腎機能重症度分類からみた心不全症例における運動療法の効果と 再入院に及ぼす影響の検討 小村 幸則(心臓血管センター金沢循環器病院 リハビリテーション部) チーム医療セッション 一般演題(ポスター)3 (O) ポスター会場 2(東京国際フォーラム A ブロック 4F, 5F, 6F ホワイエ) 10:10−11:00 事例・症例報告 1 座長: 東條 美奈子(北里大学 医療衛生学部 リハビリテーション学科) CP-014 周産期心筋症患者に対する経時的運動耐容能評価の検討 坪井 康典(神戸大学 リハビリテーション部) CP-015 心不全患者へ高流量システム(Nasal High Flow)導入で NPPV を回避した症例 嵩原 安嗣(那覇市立病院 循環器内科) CP-016 PTCRA 施行患者についての比較検討 渡部 惇(千葉西総合病院 ME室) CP-017 側枝への Stent 留置に対する治療成績 渡部 惇(千葉西総合病院 ME室) CP-018 下肢切断に至った高齢末梢動脈疾患患者に対するリハビリテー ションの経験∼近赤外線酸素モニター装置を用いた介入効果の 評価を通して∼ 鯉江 祐介(福井大学 リハビリテーション部) CP-019 栄養指導の介入でフルスルチアミン錠(アリナミンⓇ)を減量 できた脚気心の一例 山口 ひとみ(常陸大宮済生会病院 栄養科) CP-020 遠隔モニタリングシステムにより、最大出力によるショック治療 が無効であった VF 対し早期介入できた症例 山田 二三歩(横浜市立大学) 216 3月21日(金)午前 チーム医療セッション 一般演題(ポスター)4 (O) ポスター会場 2(東京国際フォーラム A ブロック 4F, 5F, 6F ホワイエ) 10:10−11:00 患者教育・カウンセリング 1!クリティカルパス 1 座長: 角口 亜希子(榊原記念病院 看護部) CP-021 5 項目の看護支援と 3 つの禁煙開始行動を取り入れた禁煙外来 支援の結果の考察 内藤 和代(岐阜大学 看護部) CP-022 心臓カテーテル検査を受ける患者の DVD を用いたオリエン テーションの導入 武藤 淳子(旭川赤十字病院 看護部) CP-023 虚血性心疾患患者の二次予防を目指した介入プログラムの効果 山田 緑(東邦大学 看護学科) CP-024 当院循環器内科の入院患者のサプリメントおよび健康食品に 対する意識調査 笹川 美千代(金沢医科大学 栄養部) CP-025 当院におけるトルバプタンの適正使用を目指したクリティカル パスの導入 日下 豊史(菊川市立総合病院 薬剤科) CP-026 看護師のクリティカルパス理解に対する学習会の効果 菊地 梓(船橋市立医療センター) CP-027 ASV 療法のクリニカルパスを導入して 大石 竜子(長野赤十字病院 循環器センター) チーム医療セッション 一般演題(ポスター)5 (O) ポスター会場 2(東京国際フォーラム A ブロック 4F, 5F, 6F ホワイエ) 10:10−11:00 クリティカルパス 2!チーム医療 1 座長: 杉野 由起子(済生会熊本病院TQM部・人材開発室) CP-028 患者教育を充実させた経皮的冠動脈形成術用パスの冠危険因子 是正へ有効性 槙垰 賢政(福岡市医師会成人病センター リハビリテーション科) CP-029 外来診療における医師事務作業補助者導入の効果 伊藤 裕子(日鋼記念病院) CP-030 ペースメーカー植え込み患者の不安軽減のための医療チームの 役割∼術前から退院後までの継時的な検討∼ 千葉 瞳(昭和大学 保健医療学部 看護学科) 217 March 21 AM 3月21日(金)午前 March 21 AM CP-031 遺伝性結合織疾患の包括的診療・サポートを目指して∼結合織病 外来の取り組み∼ 吉田 晶子(国立循環器病研究センター 臨床遺伝科) CP-032 在宅訪問診療を受けている心不全患者の 24 時間の電話コール 吉田 真希(ゆみのハートクリニック) CP-033 多職種心不全チームにおける薬剤師の役割およびその成果 田中 仁(亀田メディカルセンター 薬剤部) CP-034 維持期における心疾患管理とチームアプローチについて考える 渡辺 恵都子(千鳥橋病院 リハセンター) チーム医療セッション 一般演題(ポスター)6 (CAD) ポスター会場 2(東京国際フォーラム A ブロック 4F, 5F, 6F ホワイエ) 10:10−11:00 侵襲検査・血管内治療 1 座長: 藤田 英雄(東京大学 CP-035 循環器内科) 心臓カテーテル検査のオリエンテーションに視聴覚教材 (DVD)を使用して 平川 久美子(下関厚生病院) CP-036 Dynamic Stent View 不適応画像の検討 村岡 祐基(竹田綜合病院 放射線科) CP-037 石灰化病変に対する各種バルーン拡張能の検討 清田 佳久(小倉記念病院) CP-038 FD! OCT イメージングカテーテルの通過が責任病変遠位部の 血管内腔断面積に及ぼす影響 黒川 宗雄(奈良県立医科大学 医療技術センター) CP-039 急性心筋梗塞症の重症度とラクテート値との関係 有馬 美樹(宮崎市郡医師会病院) CP-040 STENT Deformation が認められた一例∼実験の検討も含めて∼ 中川 透(金沢医科大学 ME部) CP-041 PCI 後の心筋傷害と粥腫組成との関連についての検討 天雲 史浩(高松市民病院 臨床工学科) 218 3月21日(金)午前 チーム医療セッション 一般演題(ポスター)7 (A) ポスター会場 2(東京国際フォーラム A ブロック 4F, 5F, 6F ホワイエ) 10:10−11:00 不整脈・アブレーション 1 座長: 池田 隆徳(東邦大学 循環器内科学分野) CP-042 心房細動アブレーションにおけるフロートラックシステムの有用性 西野 功一(福岡大学 臨床工学センター) CP-043 Loop Recorder(SPIDERFLASH! t AFib)の Total QRS 値に ついての検討 岡田 典華(福山循環器病院 生理検査課) CP-044 右室ペーシングリード近位電極はどの程度心筋捕捉しているか? 市川 真嗣(伊勢赤十字病院 医療技術部 臨床検査課) CP-045 トレッドミル運動負荷試験からみた健常例 J 波の動向 齋藤 修(新潟大学 保健学研究科) CP-046 体位変換と運動に伴う QT 間隔変動と Bazette・Fredericia 補正 鈴木 克弥(木戸病院 検査科) CP-047 心房細動症例における心腔内除細動閾値と心房容積との関連の検討 坂本 好成(馬場記念病院 医療機器管理部) CP-048 心房細動アブレーションにおける ACT 値の検討 檜尾 和美(武田病院 臨床工学科) チーム医療セッション 一般演題(ポスター)8 (IM) ポスター会場 2(東京国際フォーラム A ブロック 4F, 5F, 6F ホワイエ) 10:10−11:00 非侵襲検査・エコー 1 座長: 岩永 史郎(東京医科大学八王子医療センター 循環器内科) CP-049 両心耳内に血栓を認めた心房細動の一例 奥野 菜々子(川崎医科大学 中央検査部) CP-050 超音波を用いた血管仮想内視鏡像の使用経験 安田 英明(大垣市民病院 診療検査科 血管専門検査室) CP-051 3 次元 Speckle Tracking Echo により測定される左室 Strain Rate を用いた高血圧患者の左室収縮能および拡張機能の評価 長屋 麻紀(岐阜県総合医療センター 臨床検査科) CP-052 末梢血管狭窄指標の比較検討∼超音波パルスドプラ法と観血的 検査の比較∼ 青野 拓也(済生会西条病院 臨床検査科) 219 March 21 AM 3月21日(金)午前 March 21 AM CP-053 急性大動脈解離患者の心電図所見の検討 前橋 いずみ(横浜市立みなと赤十字病院 検査部) CP-054 リアルタイム 3D 心エコー図を用いた僧帽弁の三次元的ダイナ ミック解析の試み:心臓再同期療法後急性期に機能性僧帽弁逆流 が減少したレスポンダーの 1 例 武田 恵美子(宮崎大学 検査部) CP-055 糖尿病性腎症による透析導入患者における Cardio Ankle Vascular Index および Ankle Brachial Index:透析期間および C 反応性蛋白との独立した関連 松下 隆史(田北病院) チーム医療セッション 一般演題(ポスター)9 (IM) ポスター会場 2(東京国際フォーラム A ブロック 4F, 5F, 6F ホワイエ) 10:10−11:00 非侵襲検査・エコー 2 座長: 種村 正(心臓血管研究所 臨床検査室) CP-056 硝酸薬耐性発現を FMD 及び NMD にて評価できた難治性 冠攣縮性狭心症の一例 東 奈々子(熊本機能病院 心臓生理検査課) CP-057 大動脈弁狭窄症における超音波アプローチ部位による計測値の 相違と重症度に与える影響 菊池 秀和(聖マリアンナ医科大学 臨床検査部) CP-058 石膏モデルを使った各種スコアリングバルーンの拡張効果の検討 馬場 速夫(横浜新都市脳神経外科病院 臨床工学科) CP-059 糖尿病患者における自律神経障害の CVRR の検討 嶋田 薫(九州厚生年金病院 生理検査室) CP-060 透析患者の大動脈弁狭窄症における Cardio! Ankle Vascular Index(CAVI)の有用性の検討 久世 陽香(神明病院 検査部) CP-061 Flow! Mediated Dilation 検査精度を向上させるための方法論的 検討 金原 正昭(純真学園大学 保健医療学部) 220 3月21日(金)午前 ランチョンセミナー 1 第 2 会場(東京国際フォーラム C ブロック 4! 5F ホール C) 12:50−13:40 Real World における新規経口抗凝固薬のエビデンス から学ぶ 座長: 井上 博(富山大学 第二内科) 1.新規経口抗凝固薬の市販後調査成績からの知見 池田 隆徳(東邦大学 内科学講座 循環器内科学分野) 2.実臨床から学ぶ新規経口抗凝固薬の使い方 奥村 謙(弘前大学 循環呼吸腎臓内科学講座) 共催:バイエル薬品株式会社 ランチョンセミナー 2 第 3 会場(東京国際フォーラム B ブロック 7F ホール B7(1)) 12:50−13:40 2 型糖尿病をどう捉えていますか? ―すっかり変わった糖尿病治療― 座長: 堀 正二(大阪府立成人病センター) 河盛 隆造(順天堂大学、スポートロジーセンター) 共催:大日本住友製薬株式会社 ランチョンセミナー 3 第 4 会場(東京国際フォーラム B ブロック 7F ホール B7(2)) 12:50−13:40 糖尿病患者における脂質異常症の成因と治療 座長: 横手 幸太郎(千葉大学 山下 静也(大阪大学 細胞治療内科学) 循環器内科学 総合地域医療学寄附講座) 共催:株式会社三和化学研究所 221 March 21 AM 3月21日(金)午前 March 21 AM ランチョンセミナー 4 第 5 会場(東京国際フォーラム D ブロック 7F ホール D7) 12:50−13:40 心電図で読み解く急性冠症候群の病態 座長: 前村 浩二(長崎大学 循環病態制御内科学) 小菅 雅美(横浜市立大学附属市民総合医療センター 循環器内科) 共催:フクダ電子株式会社 ランチョンセミナー 5 第 6 会場(東京国際フォーラム D ブロック 5F ホール D5) 12:50−13:40 Impella,血行動態からの補助循環の効果 座長: 中村 正人(東邦大学医療センター 大橋病院 循環器内科) Mark A. Grise(Sacred Heart Cardiology, Sacred Heart Medical Group, U.S.A.) 共催:ABIOMED, Inc. ランチョンセミナー 6 第 7 会場(東京国際フォーラム D ブロック 1F ホール D1) 12:50−13:40 Anti thrombotic therapy in the future for patients with Oral anticoagulation and PCI 座長: 阿古 潤哉(北里大学 循環器内科学) Willem Dewilde(Amphia Hospital, The Netherlands) 共催:サノフィ株式会社 222 3月21日(金)午前 ランチョンセミナー 7 第 8 会場(東京国際フォーラム ガラス棟 4F G402) 12:50−13:40 さらなる進化をみせる心臓交感神経イメージング MIBG 座長: 坂田 泰史(大阪大学 循環器内科学) 1.心不全多施設コホートデータ解析による長期生命予後評価と新たな展開 ―FDA に認められた日本の EBM― 中田 智明(函館五稜郭病院 循環器内科) 2.MIBG 定量指標 H! M 比の標準化と予後予測モデルのソフトウェア化 中嶋 憲一(金沢大学 核医学診療科) 共催:富士フイルム RI ファーマ株式会社 ランチョンセミナー 8 第 9 会場(東京国際フォーラム ガラス棟 4F G409) 12:50−13:40 循環器疾患における SAS 診療の重要性 座長: 安藤 眞一(九州大学病院 睡眠時無呼吸センター) 1.パルスオキシメータによる睡眠時無呼吸のスクリーニング 小島 淳(熊本大学 循環器内科学 心不全先端医療寄附講座) 2.冠動脈疾患と睡眠呼吸障害 横井 宏佳(福岡山王病院 循環器センター、国際医療福祉大学) 共催:帝人ファーマ株式会社! 帝人在宅医療株式会社! レスメド株式会社 223 March 21 AM 3月21日(金)午前 March 21 AM ランチョンセミナー 9 第 10 会場(東京国際フォーラム ガラス棟 5F G502) 12:50−13:40 慢性心不全治療におけるカルシウム拮抗薬への期待: Update 2014 座長: 福田 恵一(慶應義塾大学 増山 理(兵庫医科大学 循環器内科) 循環器内科) 共催:持田製薬株式会社! 味の素製薬株式会社 ランチョンセミナー 10 第 11 会場(東京国際フォーラム ガラス棟 5F G510) 12:50−13:40 血管を診る∼新たな血管指標の可能性∼ 座長: 山科 章(東京医科大学 第二内科) 1.血圧計を用いた動脈硬化度評価指標(API・AVI)の開発 小峰 秀彦(経済産業省 商務情報政策局 ヘルスケア産業課 医療福祉機器産業室) 2.機能的動脈硬化性心血管疾患診療指標の現状:Pasesa 使用の経験も踏まえて 冨山 博史(東京医科大学 第二内科) 共催:日本光電工業株式会社 ランチョンセミナー 11 第 12 会場(東京国際フォーラム ガラス棟 6F G602) 12:50−13:40 ハイリスク患者における脂質・血圧管理 ∼最新のガイドラインの知見から∼ 座長: 伊藤 裕(慶應義塾大学 腎臓内分泌代謝内科) 糖尿病患者の冠動脈疾患リスクをいかに管理するか 田中 正巳(慶應義塾大学 腎臓内分泌代謝内科) 共催:アステラス製薬株式会社! ファイザー株式会社 224 3月21日(金)午前 ランチョンセミナー 12 第 13 会場(東京国際フォーラム ガラス棟 6F G610) 12:50−13:40 PCI 戦略に活かす虚血評価 座長: 倉林 正彦(群馬大学 臓器病態内科学) 1.予後改善を目指した PCI 戦略 松本 直也(駿河台日本大学 循環器科) 2.低侵襲インターベンションと BMIPP シンチによる虚血評価 吉町 文暢(東海大学 循環器内科) 共催:日本メジフィジックス株式会社 ランチョンセミナー 13 第 14 会場(東京国際フォーラム ガラス棟 7F G701) 12:50−13:40 心血管疾患発症阻止を見据えた血糖管理:夜間深夜帯の 血糖変動、交感神経活動、血圧変動の視点から ―CGM、ホルタ―ECG、ABPM 同時装着による検討― 座長: 木原 康樹(広島大学 循環器内科学) 森 豊(東京慈恵会医科大学 糖尿病・代謝・内分泌内科) 共催:田辺三菱製薬株式会社! 第一三共株式会社 225 March 21 AM 3月21日(金)午前 March 21 AM ランチョンセミナー 14 第 15 会場(東京国際フォーラム B2F セミナー室 1) 12:50−13:40 心血管病におけるサプリメントの有効性について 座長: 一色 高明(帝京大学 循環器内科) 1. 「心血管病におけるサプリメントの有効性検証研究会」の症例報告 ∼心血管病におけるサプリメントの有効性に関する臨床研究の結果に ついて∼ 辻 貴史(草津ハートセンター) 2.心血管病に有効とされているサプリメント素材について 桜田 真己(所沢ハートセンター) 共催:株式会社カネカ ランチョンセミナー 15 第 16 会場(東京国際フォーラム B2F セミナー室 2) 12:50−13:40 より質の高い高血圧治療を目指して∼肥満、食塩、尿酸∼ 座長: 長田 太助(自治医科大学 大屋 祐輔(琉球大学 腎臓内科) 循環器・腎臓・神経内科学) 共催:MSD 株式会社 226 3月21日(金)午前 ランチョンセミナー 16 第 17 会場(JP タワー 4F ホール 1! 2) 12:50−13:40 超音波検査の国産技術:3D TEE と VFM 座長: 竹中 克(日本大学板橋病院 循環器内科) 1.弁膜症に対する 3D TEE の実用性を確認する 許 俊鋭(東京都健康長寿医療センター) 2.弁膜症に対する VFM の応用の可能性を探る 中谷 敏(大阪大学 保健学専攻機能診断科学講座) 共催:日立アロカメディカル株式会社 ランチョンセミナー 17 第 18 会場(JP タワー 4F ホール 3) 12:50−13:40 心腎連鎖の克服を目指した糖尿病治療 座長: 堀内 正嗣(愛媛大学 分子心血管生物・薬理学) 古家 大祐(金沢医科大学 糖尿病・内分泌内科学) 共催:日本ベーリンガーインゲルハイム株式会社 日本イーライリリー株式会社 ランチョンセミナー 18 第 19 会場(JP タワー 4F カンファレンスルーム A) 12:50−13:40 本邦における新規エビデンス 座長: 山崎 力(東京大学 臨床研究支援センター) 糖尿病治療におけるスタチンのベネフィットとリスクを考える ∼J! PREDICT 試験の結果を踏まえて∼ 小田原 雅人(東京医科大学 内科学第三講座) 共催:興和創薬株式会社 227 March 21 AM 3月21日(金)午前 March 21 AM ランチョンセミナー 19 第 20 会場(JP タワー 5F カンファレンスルーム B) 12:50−13:40 抗凝固剤関連 座長: 池田 宇一(信州大学 循環器内科学講座) 1.循環器専門医に役立つ抗凝固剤の基礎 小嶋 哲人(名古屋大学 病態解析学講座) 2.新規抗凝固薬二つのキーワード:ガイドラインと薬物動態 山下 武志(心臓血管研究所) 共催:第一三共株式会社 ランチョンセミナー 20 第 22 会場(東京商工会議所 7F 国際会議場) 12:50−13:40 The Ultimate DES has Arrived: PROMUS 座長: 五十嵐 慶一(北海道社会保険病院) 1.青木 二郎(三井記念病院) 2.小川 崇之(東京慈恵会医科大学) 3.濱嵜 裕司(昭和大学) 共催:ボストン・サイエンティフィック ジャパン株式会社 228
© Copyright 2024 ExpyDoc